rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCATAACAGGAGGGGAGACCCAGTACTTCGGGCCA	CASSITGGETQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	0	5	6	0	23	35	-1	41	47			01,02										Vb 1	CASSITGGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGGACAGGGGAGGCCTGAAGCTTTCTTTGGACAA	CASSAGQGRPEAFF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	6	2	4	23	36	47	38	51			01,02										Vb 1	CASSAGQGRPEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGCGGTCCGGGTCACTGAAGCTTTCTTTGGACAA	CASSEAVRVTEAFF	In	VDJ	1	28	0.0012333171827511782	0.001539730547154248	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	6	5	4	3	7	23	34	42	37	49			01,02			01,02							Vb 1	CASSEAVRVTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCCGGGACTAGCGGGAGGCTCTGATACGCAGTATTTTGGCCCA	CASSSPGLAGGSDTQYF	In	VDJ	1	48	0.0021142580275734482	0.002639538080835854	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	1	6	5	4	23	35	55	40	59			01,02										Vb 1	CASSSPGLAGGSDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCCCGGGACAGGGGAGTGAAAAACTGTTTTTTGGCAGT	CASSQVPGQGSEKLFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	2	7	4	2	29	45	59	49	61													Vb 16	CASSQVPGQGSEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGCTGGACAGGGGGCACTACTATGGCTACACCTTCGGTTCG	CASSPLDRGHYYGYTF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	0	3	4	3	29	42	57	46	60													Vb 16	CASSPLDRGHYYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTCGAGCAGGGGGCTATGAGACCCAGTACTTCGGGCCA	CASSQGRAGGYETQYF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	5	6	3	29	45	59	51	62													Vb 16	CASSQGRAGGYETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCAAGCGAAGTTTTACAGAGTTACAATGAGCAGTTCTTCGGGCCA	CASSSSEVLQSYNEQFF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	5	3	5	4	14	3	29	41	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSSSEVLQSYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATCGGGGGAGTTCTGGAAACACCATATATTTTGGAGAG	CASSHRGSSGNTIYF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	2	1	1	3	29	43	50	44	53													Vb 16	CASSHRGSSGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGGGACTATGGTGGAGACCCAGTACTTCGGGCCA	CASSQGGTMVETQYF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	9	5	2	5	29	45	54	47	59						01,02							Vb 16	CASSQGGTMVETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAGGAGGGTCCTAGCGGGATTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	0.0017618816896445403		55	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	3	2	10	3	26	42	61	52	64													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAACTAGCGGGGCGGGGAATGAGCAGTTCTTCGGGCCA	CASSLTSGAGNEQFF	In	VDJ	1	40	0.0017618816896445403	0.0021996150673632116	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	7	2	5	29	42	54	44	59													Vb 16	CASSLTSGAGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGACGGTCGGGGAGCTGTTTTTTGGAGAA	CASSPTVGELFF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	4	2	7	7	1	3	29	42	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPTVGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCAAATATCCGAGGGATTGAACACTGAAGCTTTCTTTGGACAA	CASSQISEGLNTEAFF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	0	6	2	29	44	55	50	57													Vb 16	CASSQISEGLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTACCAGCAGCCGTCAGGGGCTCATACAGGGCGCCGAAGCTTTCTTTGGACAA	CTSSRQGLIQGAEAFF	In	VDJ	1	44	0.0019380698586089944	0.0024195765740995328	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	8	13	4	29	42	61	55	65													Vb 16	CTSSRQGLIQGAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCGACCCCAGGGTACGAGCAGTACTTCGGGCCG	CASSSTPGYEQYF	In	VDJ	1	45	0.001982116900850108	0.002474566950783613	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	4	7	0	29	41	-1	48	53													Vb 16	CASSSTPGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGGATTTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRDFATNEKLFF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	4	0	8	0	0	5	29	-1	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRDFATNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGTTATCAGACAACTATGGCTACACCTTCGGTTCG	CASSGLSDNYGYTF	In	VDJ	1	57	0.00251068140774347	0.0031344514709925764	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	5	0	9	2	0	9	29	-1	44	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSGLSDNYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGAAGGAACACGGCCTCCTCAGTACTTCGGGCCG	CASSQEGTRPPQYF	In	VDJ	2	65	0.002863057745672378	0.0035743744844652188	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	1	8	10	0	16	29	-1	46	43	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQEGTRPPQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGCCCGGGGGGGACCCAGTACTTCGGGCCA	CASSQSPGGTQYF	In	VDJ	11	437	0.019248557459366603	0.024030794610943085	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	1	7	4	0	29	44	-1	48	55													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAAAAGGGCCGACAGGCCCCTCCAGTATACGCAGTATTTTGGCCCA		Out	VDJ	20	790	0.034797163370479674		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	7	10	10	28	41	57	51	67													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGGGACAGGGCCCTGAAGCTTTCTTTGGACAA	CASSGGQGPEAFF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	6	2	2	24	36	47	38	49														CASSGGQGPEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCTGGGACAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSAGTASTDTQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	0	4	2	24	35	46	39	48														CASSAGTASTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGGGTTATCCTTAGGTCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASRGLSLGHE*KTYGYTF	Stop	VDJ	1	21	9.249878870633837E-4		57	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	6	2	4	0	26	24	-1	39	35	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGLSLGHE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTCGACTAGCGGGCACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	0.0010571290137867241		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	4	0	4	2	24	36	50	40	52						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGCGAGAGTTTCACAGATACGCAGTATTTTGGCCCA	CASGESFTDTQYF	In	VDJ	1	27	0.0011892701405100648	0.0014847401704701677	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	7	5	2	0	9	24	-1	35	31	44						01,02								CASGESFTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCATCCCTACAGGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSGIPTGSTGELFF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	4	9	2	24	36	51	45	53														CASSGIPTGSTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACATTACCTCTGGAAACACCATATATTTTGGAGAG	CASSADITSGNTIYF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	0	2	4	24	36	43	38	47														CASSADITSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTGGGCAAGGGGGTGGGAGACCCAGTACTTCGGGCCA	CASWARGWETQYF	In	VDJ	2	61	0.002686869576707924	0.0033544129777288976	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	5	1	5	8	3	24	31	45	39	48														CASWARGWETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCTGTGTATCTCTGTGCCAGACAGCGCCCCGGGTTGGCTTATCATGGCTACACCTTCGGTTCG	CARQRPGLAYHGYTF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	6	6	6	1	17	19	28	33	29	50						01,02								CARQRPGLAYHGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCAAGGGTCATTACCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSKGHYPQSRANVLTF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	54	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-06	01	4	5	3	5	1	17	19	31	36	32	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGHYPQSRANVLTF+TCRBV07-05+TCRBJ02-06	TCRBV07-05*01		TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGGACACACCCCCCCGAGGGAAGCTTTCTTTGGACAA	CASSEGHTPPREAFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	2	6	8	0	13	23	-1	43	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGHTPPREAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACAGGGAATTCAGCCCCAGCATTTTGGTGAT	CASSEGQGIQPQHF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	6	0	3	23	-1	46	39	49														CASSEGQGIQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGTAGCCTAACCCAGGGGGCGCGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	7.047526758578161E-4		47	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	5	6	4	22	34	48	40	52														X+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAATGGCGTCGCCGGGGAGCTGTTTTTTGGAGAA	CAWSVNGVAGELFF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-02	01	0	9	0	6	4	4	26	40	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVNGVAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGACTCCCATCTATGGCTACACCTTCGGTTCG	CAWSVTPIYGYTF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	2	10	4	0	5	26	-1	44	40	49						01,02							Vb 20	CAWSVTPIYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGAATACTAGCGGCTTATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	7.047526758578161E-4		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	3	5	5	26	35	48	40	53						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGCCACTGGCTGGGGGGAACATTCAGTACTTCGGCGCC	CAWGPLAGGNIQYF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	9	1	7	12	0	26	35	-1	47	53													Vb 20	CAWGPLAGGNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGAAGACTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CARRLAGGNEQFF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	2	1	6	4	0	26	32	-1	36	49													Vb 20	CARRLAGGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCTTTATCTCTGGCGGGGGTACGCAGTATTTTGGCCCA	CAWGFISGGGTQYF	In	VDJ	1	37	0.0016297405629211999	0.0020346439373109706	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	8	13	0	26	35	-1	48	55													Vb 20	CAWGFISGGGTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGACAGGGACGGGGACTTCGGGCCG	CAWSADRDGDF	In	VDJ	1	46	0.0020261639430912215	0.002529557327467693	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	14	2	6	26	39	48	41	54			unresolved										Vb 20	CAWSADRDGDF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAATGGGCAGGGTTCGAATCAGCCCTAGCATTTTGGTGAT	CAWDNGQGSNQP*HF	Stop	VDJ	1	47	0.002070210985332335		45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	14	9	14	26	35	49	44	63													Vb 20	CAWDNGQGSNQP*HF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGAACGGGAGTAGGAGTCCCCGGTACTTCGGGCCG		Out	VDJ	1	51	0.002246399154296789		44	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	12	6	12	26	39	51	45	63			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWSVTGSGNTIYF	In	VDJ	1	54	0.0023785402810201296	0.0029694803409403355	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	3	1	1	0	26	40	-1	41	47			unresolved										Vb 20	CAWSVTGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGTAGGAGACCCAGTACTTCGGGCCA	CAWSVR*ETQYF	Stop	VDJ	1	57	0.00251068140774347		36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	8	5	4	0	26	40	-1	44	47						01,02							Vb 20	CAWSVR*ETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGATAGGACTAGCGGGAGTTGGGAGCAGTTCTTCGGGCCA		Out	VDJ	2	60	0.0026428225344668106		43	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	2	10	3	4	26	37	53	40	57			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGTCCACGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSVVHASSYNEQFF	In	VDJ	2	65	0.002863057745672378	0.0035743744844652188	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	6	0	7	2	26	40	50	47	52						01,02							Vb 20	CAWSVVHASSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACTCAAAACATTCAGTACTTCGGCGCC	CAWSTQNIQYF	In	VDJ	2	74	0.0032594811258423997	0.004069287874621941	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	3	10	5	0	1	26	-1	41	38	42						01,02							Vb 20	CAWSTQNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCTCTGACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	3	131	0.00577016253358587	0.007203739345614518	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-04	01	0	2	7	0	4	2	26	40	47	44	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01		TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCTCGTCCCCGGACAGGGATGGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	189	0.008324890983570454		49	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	3	5	11	3	26	38	57	49	60													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTCATCCCGGCCAGGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CAWTHPGQGLQETQYF	In	VDJ	5	202	0.008897502532704929	0.011108056090184218	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	1	11	3	26	36	52	47	55			unresolved										Vb 20	CAWTHPGQGLQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACGATTATCATGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	5.726115491344756E-4		49	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	0	6	1	3	11	0	23	40	-1	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGTTTACAATGAGCAGTTCTTCGGGCCA	CASSQVYNEQFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	3	0	10	4	0	2	23	-1	39	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTCTCGGGCAGGGGACACACAACACTGAAGCTTTCTTTGGACAA	CASSQVLGQGTHNTEAFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	6	2	11	3	23	39	56	50	59														CASSQVLGQGTHNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACGGCCAGTTCGGGACAGGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSHGQFGTGVADTQYF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	4	10	3	23	37	57	47	60														CASSHGQFGTGVADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGAGACAGGGCCCTATTTTGAAGCTTTCTTTGGACAA	CASSQETGPYFEAFF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	7	3	8	23	37	47	40	55														CASSQETGPYFEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGTGTCCGGTAATTCAGACGCCATATATTTTGGAGAG	CASSQGVSGNSDAIYF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-03	01	1	0	9	11	0	18	23	-1	42	39	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVSGNSDAIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGACAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSQETGRNTEAFF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	1	0	2	23	-1	47	40	49														CASSQETGRNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTATTATTCGTTTGTGCACAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	0.0011892701405100648		53	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	3	6	5	16	3	23	34	53	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGGGGGACTACTCCTAGAGAYCCAGTACTTCGGGCCA	CASSLGGGLLLEXQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	9	10	4	11	19	35	46	39	57						01,02							Vb 5.1	CASSLGGGLLLEXQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACAGGGGGCTTTCGGGACATTCAGTACTTCGGCGCC	CASSTGGFRDIQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	3	0	8	0	7	19	-1	40	31	47													Vb 5.1	CASSTGGFRDIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGCGGAGGACAGGAAAGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	18	7.928467603400431E-4		55	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	4	1	6	6	19	34	47	40	53													Vb 5.1	X+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAACGGGAGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLNGRTSTDTQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	2	0	3	4	19	33	42	36	46													Vb 5.1	CASSLNGRTSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATGGAACAGGGGGCGTTGAAAAACTGTTTTTTGGCAGT	CASSQDGTGGVEKLFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	0	7	9	2	19	31	49	40	51													Vb 5.1	CASSQDGTGGVEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGGCAGCGGGGGGGCCTCCGAGCAGTACTTCGGGCCG	CASSQGSGGASEQYF	In	VDJ	1	46	0.0020261639430912215	0.002529557327467693	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	6	6	4	19	31	47	37	51													Vb 5.1	CASSQGSGGASEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGCGGATTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	5.285645068933621E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	7	5	0	5	2	25	36	45	41	47						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGATTAGCGGGGGGGGAGCAGTACTTCGGGCCG	CASSPRLAGGEQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	0	7	8	0	25	36	-1	44	55													Vb 3	CASSPRLAGGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCACCGAGACAGAGCAGTTCTTCGGGCCA	CASSRTETEQFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	10	8	0	25	37	-1	45	49													Vb 3	CASSRTETEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGAGACACAGGGGCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGRHRGDSNQPQHF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	2	0	8	3	25	39	54	47	57													Vb 3	CASSFGRHRGDSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGCTCCCCGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CAGSPGAQETQYF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	11	6	0	1	8	0	25	31	-1	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAGSPGAQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGCAGGGGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRAGGGNQPQHF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	0	2	5	1	25	36	49	41	50													Vb 3	CASSRAGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTCCAGGGCACAGATACGCAGTATTTTGGCCCA	CASSFVQGTDTQYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	4	1	4	0	25	39	-1	43	47													Vb 3	CASSFVQGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTACCTTTAACAGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSSTFNSGNTEAFF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	5	1	11	0	25	38	-1	49	54						01,02							Vb 3	CASSSTFNSGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTAGACAGGCCCCGTCGGGTATCTATGGCTACACCTTCGGTTCG	CASSSRQAPSGIYGYTF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	13	25	38	47	41	60													Vb 3	CASSSRQAPSGIYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAGCGGGAGGGGAAGATACGCAGTATTTTGGCCCA	CASSLLAGGEDTQYF	In	VDJ	1	35	0.0015416464784389727	0.00192466318394281	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	0	5	0	2	25	-1	52	40	54													Vb 3	CASSLLAGGEDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCAGGGAGCGTACACTGAAACTTTCTTTGGACAA		Out	VDJ	1	37	0.0016297405629211999		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	4	3	12	2	14	25	36	43	38	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGACGGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSWTGQMNTEAFF	In	VDJ	1	47	0.002070210985332335	0.0025845477041517733	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	4	1	25	38	49	42	50													Vb 3	CASSWTGQMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSLSGSGNTIYF	In	VDJ	1	58	0.0025547284499845835	0.0031894418476766566	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	3	1	0	0	25	-1	-1	41	46													Vb 3	CASSLSGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCGGGACGGATATTCAGCCCCAGCATTTTGGTGAT	CASSLGGTDIQPQHF	In	VDJ	2	82	0.003611857463771308	0.004509210888094584	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	7	3	6	2	7	25	39	47	41	54													Vb 3	CASSLGGTDIQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTTGGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFVGGSSYNEQFF	In	VDJ	4	161	0.007091573800819275	0.008853450646136926	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	0	5	0	25	39	-1	44	51													Vb 3	CASSFVGGSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGTTAAGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSLRGSNQPQHF	In	VDJ	9	348	0.015328370699907501	0.019136651086059938	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	1	5	1	25	38	48	43	49													Vb 3	CASSSLRGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGTTCGAGCGGGAGGATCCACAATGAGCAGTTCTTCGGGCCA	CASSSGRIHNEQFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	1	5	3	4	18	27	39	30	43														CASSSGRIHNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGCACAGGGAACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	0.0014095053517156322		49	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	0	2	2	18	35	43	37	45														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCCTTCGACAGGGTGGGAATTCACCCCTCCACTTTGGGAAC	CASLRQGGNSPLHF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	2	3	7	4	4	23	32	43	36	47													Vb 14	CASLRQGGNSPLHF+TCRBV27-01+TCRBJ01-06	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGGTTCAGGGACAGGGGGATTTGGCTACACCTTCGGTTCG	CASGSGTGGFGYTF	In	VDJ	1	29	0.0012773642249922917	0.0015947209238383283	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	7	2	3	23	36	49	38	52													Vb 14	CASGSGTGGFGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTATTAAGGTGGACAGGGAGGGTCATTGAAGCTTTCTTTGGACAA	CSVLRWTGRVIEAFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	7	8	8	25	33	49	41	57													Vb 4	CSVLRWTGRVIEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCAGGGGCAGAGCTATGGCTACACCTTCGGTTCG	CSVDQGQSYGYTF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	4	1	5	25	36	43	37	48													Vb 4	CSVDQGQSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGATTCAGGGTCTGGAAACACCATATATTTTGGAGAG	CSVDSGSGNTIYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	1	5	0	25	33	-1	38	43													Vb 4	CSVDSGSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCACGACGGAGAGTCCGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	0.0010130819715456108		34	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	8	4	6	12	0	25	29	-1	41	45						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGAAATCCGGGGAGGGAACACTGAAGCTTTCTTTGGACAA	CSAEIRGGNTEAFF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	1	5	0	25	37	-1	42	48													Vb 4	CSAEIRGGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCTCTGCAGCGTTGAAGGGGAGGGACTGGGGACTAGCGGGAGGAAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEGEGLGTSGRKGSYNEQFF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	66	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	1	0	11	5	4	17	43	28	48													Vb 4	CSVEGEGLGTSGRKGSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACATCAGGGGTGGCAACACTGAAGCTTTCTTTGGACAA	CSVDIRGGNTEAFF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	2	3	4	25	36	45	39	49													Vb 4	CSVDIRGGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGCGGGATTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVSGISSYNEQFF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	3	0	1	4	25	33	41	34	45													Vb 4	CSVSGISSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCTCAGGGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CSVEAQGAGNTEAFF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	0	1	2	3	25	38	48	40	51													Vb 4	CSVEAQGAGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCGACTAGCGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CSGRLAGDYNEQFF	In	VDJ	1	46	0.0020261639430912215	0.002529557327467693	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	2	2	3	3	1	25	32	47	35	48													Vb 4	CSGRLAGDYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTTGGGACACGAAACACCGGGGAGCTGTTTTTTGGAGAA	CSVFGTRNTGELFF	In	VDJ	1	51	0.002246399154296789	0.0028045092108880945	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	2	3	3	25	34	43	37	46													Vb 4	CSVFGTRNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACCCCCCAAGGAGCTGGGGAGCTGTTTTTTGGAGAA	CSVTPQGAGELFF	In	VDJ	1	54	0.0023785402810201296	0.0029694803409403355	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	2	8	9	2	25	34	47	43	49													Vb 4	CSVTPQGAGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGGTTTGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSVAVWGQETQYF	In	VDJ	1	55	0.002422587323261243	0.0030244707176244156	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	4	6	2	1	6	0	25	35	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAVWGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCAACAGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	91	0.0040082808439413295		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	4	3	0	25	35	-1	38	46													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTCCCCGACTAGCGGGACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPRLAGPSTDTQYF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	57	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	2	3	0	9	3	22	35	55	44	58														CASSLGPRLAGPSTDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCAGACTAGCGGGGTTGACAGATACGCAGTATTTTGGCCCA	CATRLAGLTDTQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	3	0	3	23	-1	44	34	47													Vb 12	CATRLAGLTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCCTCCCCCACACGGGGCATACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	9.690349293044972E-4		47	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	7	7	0	3	13	2	23	33	51	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTTGCACGCAACGAGCAGTACTTCGGGCCG	CASSEFARNEQYF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	1	3	7	5	4	3	23	39	45	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEFARNEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTCCTGACAGCGGGAGGGCCCCTACGAGCAGTACTTCGGGCCG	CASS*QREGPYEQYF	Stop	VDJ	1	36	0.0015856935206800863		45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	6	0	2	7	2	23	32	49	39	51													Vb 12	CASS*QREGPYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGACTATCCCGACGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	40	0.0017618816896445403		43	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	9	6	0	8	23	-1	41	36	49						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCCGCCTAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATRLSSGANVLTF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	10	4	9	0	5	2	23	30	38	35	40						01,02							Vb 12	CATRLSSGANVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01	TCRBD02-01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCGTCTAACACCGGAGGGGGAACCCTTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	73	0.003215434083601286		53	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	11	5	1	1	12	8	23	29	47	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCTCCCTCGCAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPSQGNTEAFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	3	1	11	0	24	31	-1	42	47													Vb 12	CASSPSQGNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCACAGGGGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	17	7.487997180989297E-4		38	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	7	0	1	23	-1	47	40	48													Vb 12	X+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATGGGAGACGGGGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CAMGDGGPSTDTQYF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	8	1	0	6	3	24	32	45	38	48													Vb 12	CAMGDGGPSTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGATGGATTGGGGCAAGAGACCCAGTACTTCGGGCCA	CASNDGLGQETQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	7	6	2	2	10	0	27	37	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNDGLGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGGTACAGATACGCAGTATTTTGGCCCA	CASSIFGTDTQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	0	10	3	4	1	27	41	47	45	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCCATCAGGGTGATGGGTTACAATGAGCAGTTCTTCGGGCCA	CASTSIRVMGYNEQFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	4	7	8	27	37	49	44	57			01,02										Vb 17	CASTSIRVMGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACATCCCGGGAACAGCTCAATCAGCCCCAGCATTTTGGTGAT	CASTSREQLNQPQHF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	9	8	3	3	7	6	27	35	47	42	53			01,02										Vb 17	CASTSREQLNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGGGTTCGGCCTCCCTTCTGGAAACACCATATATTTTGGAGAG	CASSRQGFGLPSGNTIYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	2	1	0	12	27	-1	48	40	60			01,02										Vb 17	CASSRQGFGLPSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGCCCAGGGTACCACGAGCAGTACTTCGGGCCG	CASSIRPGYHEQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	5	4	4	27	42	51	46	55			01,02										Vb 17	CASSIRPGYHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGAGGGAAAGCCCCGAGCAGTACTTCGGGCCG	CASSIERESPEQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	6	0	7	27	-1	49	44	56			01,02										Vb 17	CASSIERESPEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCCCTCCAGGGATTCACATGTGGCTACACCTTCGGTTCG	CASPLQGFTCGYTF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	4	3	7	7	9	27	35	47	42	56			01,02										Vb 17	CASPLQGFTCGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGGATCCCAATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	8.809408448222702E-4		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	3	4	0	7	27	-1	46	40	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGACGGGGGAACACGAGCAGTACTTCGGGCCG	CASSITTGEHEQYF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	5	4	3	27	42	52	46	55			01,02										Vb 17	CASSITTGEHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGGTCTTCCTACGAGCAGTACTTCGGGCCG	CASSIRSSYEQYF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	5	1	1	3	27	41	45	42	48			01,02			01,02							Vb 17	CASSIRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCTGGAAATGAGCAGTTCTTCGGGCCA	CASSISGNEQFF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	1	8	7	4	0	27	41	-1	45	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATACGCCGGCCCCAGGCGGGGGACACTGAAGCTTTCTTTGGACAA	CASIRRPQAGDTEAFF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	7	2	3	14	0	27	37	-1	51	58			01,02										Vb 17	CASIRRPQAGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGCTCGGACAGGGGGCAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	0.0014095053517156322		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	1	0	2	4	2	27	33	48	37	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGGGGGAGGGTATGGTGATCAGCCCCAGCATTTTGGTGAT	CASSSGGGYGDQPQHF	In	VDJ	1	33	0.0014535523939567458	0.0018146824305746495	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	1	5	1	11	27	39	47	40	58			01,02			01,02							Vb 17	CASSSGGGYGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGCCCCCGGGAGAGACCCAGTACTTCGGGCCA	CASSIRPPGETQYF	In	VDJ	1	37	0.0016297405629211999	0.0020346439373109706	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	4	8	0	27	41	-1	49	53			01,02			01,02							Vb 17	CASSIRPPGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGTGGGTTCTTTCTTTGGGGCAGATACGCAGTATTTTGGCCCA	CASTPVGSFFGADTQYF	In	VDJ	1	38	0.0016737876051623134	0.002089634313995051	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	7	6	2	4	20	0	27	37	-1	57	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPVGSFFGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCGGCAAAGGGCTACACCTTCGGTTCG	CASSIPAKGYTF	In	VDJ	1	38	0.0016737876051623134	0.002089634313995051	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	9	0	8	3	4	27	41	47	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPAKGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCACAGAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSQRSTDTQYF	In	VDJ	1	39	0.0017178346474034268	0.002144624690679131	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	3	5	0	2	3	27	36	42	38	45			01,02										Vb 17	CASSQRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAAGACAGACCTATGGCTACACCTTCGGTTCG	CASSGRQTYGYTF	In	VDJ	1	41	0.001805928731885654	0.002254605444047292	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	4	4	2	27	39	48	43	50			01,02										Vb 17	CASSGRQTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGGACTTACGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSIRGLTGQETQYF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	4	2	2	0	10	27	-1	47	41	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRGLTGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRGANTGELFF	In	VDJ	1	44	0.0019380698586089944	0.0024195765740995328	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	7	0	0	0	1	27	-1	45	40	46			01,02										Vb 17	CASSRGANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGAGTGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSKSAGSYNEQFF	In	VDJ	1	45	0.001982116900850108	0.002474566950783613	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	1	5	0	27	40	-1	45	51			01,02										Vb 17	CASSKSAGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCCGGGACAGCGCAAAGGCGGTACTTCGGGCCG	CASSISGTAQRRYF	In	VDJ	1	48	0.0021142580275734482	0.002639538080835854	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	12	4	10	27	41	52	45	62			01,02										Vb 17	CASSISGTAQRRYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGTCACCGAGCAGTTCTTCGGGCCA	CASSIGVTEQFF	In	VDJ	1	52	0.0022904461965379025	0.0028594995875721747	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	10	1	5	27	41	46	42	51			01,02										Vb 17	CASSIGVTEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTTACAGGGGTCTCCGAGCAGTACTTCGGGCCG	CASSFTGVSEQYF	In	VDJ	2	59	0.002598775492225697	0.003244432224360737	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	6	4	4	27	38	49	42	53			01,02										Vb 17	CASSFTGVSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGACAGGGTTATACGAGCAGTACTTCGGGCCG	CASSIRTGLYEQYF	In	VDJ	2	62	0.0027309166189490378	0.003409403354412978	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	4	2	3	27	41	51	43	54			01,02										Vb 17	CASSIRTGLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGGGACAGGGCAAAAGAAAAACTGTTTTTTGGCAGT	CASWDRAKEKLFF	In	VDJ	2	63	0.002774963661190151	0.003464393731097058	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	3	8	1	5	27	36	46	37	51			01,02										Vb 17	CASWDRAKEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCGGGAGCTAGGTACGCAGTATTTTGGCCCA	CASSIGRELGTQYF	In	VDJ	2	67	0.002951151830154605	0.003684355237833379	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	2	8	1	5	27	43	51	44	56			01,02										Vb 17	CASSIGRELGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGGATGAGCGGAGCCCAAGAGACCCAGTACTTCGGGCCA	CATRMSGAQETQYF	In	VDJ	3	127	0.005593974364621415	0.006983777838878196	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	6	5	1	8	3	27	34	47	42	50			01,02			01,02							Vb 17	CATRMSGAQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGACTAGTTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	16	7.047526758578161E-4		38	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	8	5	0	3	23	-1	43	36	46						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTGTAAAATAACTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	0.0011011760560278377		49	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	12	5	23	35	51	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAAACTAGCGGGATGGGATACGCAGTATTTTGGCCCA	CASKLAGWDTQYF	In	VDJ	3	107	0.004713033519799146	0.005883970305196591	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	3	3	6	1	3	23	33	44	34	47													Vb 11	CASKLAGWDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCATAAGGTCCGGTATGGACACTGAAGCTTTCTTTGGACAA	CATIRSGMDTEAFF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	10	5	4	3	5	10	26	33	41	38	51		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATIRSGMDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCTACTAGCGGGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSTSGGTNTGELFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	3	1	0	1	1	24	41	54	42	55		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYSTSGGTNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCGTAGCGGGATAAACAATGAGCAGTTCTTCGGGCCA	CASSRSGINNEQFF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	5	2	3	19	31	41	33	44		TCRBV07-05,TCRBV07-06												CASSRSGINNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGTTGGGCAGGGAAATAAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	6.166585913755891E-4		46	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	6	8	18	32	43	38	51		TCRBV07-02,TCRBV07-06												X+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTCGGGGGAACCAATCAGCCCCAGCATTTTGGTGAT	CASSFGGTNQPQHF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	2	3	0	3	19	-1	39	33	42		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSFGGTNQPQHF+TCRBV05-X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCAACATCCTGGGGGAGACCCAGTACTTCGGGCCA	CASSNILGETQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	5	6	2	5	8	0	22	34	-1	42	46		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNILGETQYF+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAATGAACGGAGCCCGAAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNERSPKSSGANVLTF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	10	2	0	6	9	23	33	43	39	52		TCRBV06-04,TCRBV06-08												CASNERSPKSSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTTCCTCAGCACAGATACGCAGTATTTTGGCCCA	CASSFLSTDTQYF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	10	0	2	1	23	36	40	38	41		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								CASSFLSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAACGGGTGGGGTATGGAATGAGCAGTTCTTCGGGCCA	CASRTGGVWNEQFF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	6	6	2	7	7	5	26	37	48	44	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGGVWNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCCTTCACGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLHENTGELFF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-02	01	5	2	8	1	6	0	19	31	-1	37	39		TCRBV07-02,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLHENTGELFF+TCRBV07-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCGAGACAGGCGAGTAACACTGAAGCTTTCTTTGGACAA	CASSPRQASNTEAFF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	2	5	5	23	34	45	39	50		TCRBV06-07,TCRBV06-08												CASSPRQASNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTCAGGGGGCAAGGGACTGAAGCTTTCTTTGGACAA	CASSLRGQGTEAFF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	5	2	5	19	31	41	33	46		TCRBV11-01,TCRBV11-03												CASSLRGQGTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGACGCGGGGATGAAAAACTGTTTTTTGGCAGT	CASSYGRGDEKLFF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	7	3	6	4	0	26	41	-1	45	51		TCRBV06-07,TCRBV06-08												CASSYGRGDEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCCCCCGGACTCCTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSSPGLLAGELFF	In	VDJ	1	35	0.0015416464784389727	0.00192466318394281	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	10	6	5	5	18	31	41	36	46		TCRBV11-01,TCRBV11-03				01,02								CASSSPGLLAGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGAAGGGGGGTCTTGGCCCAGGGTTTCTTTGGACAA	CASRRGVLAQGFF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	6	5	1	13	1	14	23	34	41	35	55		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGVLAQGFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGATTCTTGTTCGGAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASRFLFGSTGELFF	In	VDJ	2	71	0.003127339999119059	0.0039043167445697003	45	TCRBV11	unresolved					TCRBJ02	TCRBJ02-02	01	6	1	8	4	10	2	19	30	43	40	45		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFLFGSTGELFF+TCRBV11-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCGAGGGACACACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSRDTLAKNIQYF	In	VDJ	3	129	0.0056820684491036425	0.0070937585922463565	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	6	0	3	4	18	31	40	34	44		TCRBV11-01,TCRBV11-03												CASSSRDTLAKNIQYF+TCRBV11-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCGAAGACAGGGACTATCTATGGCTACACCTTCGGTTCG	CASSPKTGTIYGYTF	In	VDJ	6	218	0.009602255208562746	0.011987902117129502	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	6	2	3	4	6	5	23	34	47	40	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKTGTIYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACGGACAGGGCAACGGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASTDRATGGAKNIQYF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	1	3	0	1	10	23	33	42	34	52													Vb 22	CASTDRATGGAKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTAACAGGGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASNREDTGELFF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-02	01	9	3	3	3	2	3	23	31	39	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASNREDTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATGGGCTAGCGGGACTGTCTACAATGAGCAGTTCTTCGGGCCA	CASSEWASGTVYNEQFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	3	4	4	23	38	51	42	55													Vb 22	CASSEWASGTVYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGGGACAGATTACTACGAGCAGTACTTCGGGCCG	CASRGTDYYEQYF	In	VDJ	1	55	0.002422587323261243	0.0030244707176244156	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	3	1	4	23	34	42	35	46													Vb 22	CASRGTDYYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGGACAGGCCTCCCTACGAGCAGTACTTCGGGCCG	CASSGDRPPYEQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	42	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	2	0	4	28	-1	49	41	53			01,02											CASSGDRPPYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAACGGACAGGGCTTCAGGTGAGCAGTTCTTCGGGCCA	CASSETDRASGEQFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	9	3	7	28	42	53	45	60			01,02											CASSETDRASGEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGGACGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASSEGRASGNTIYF	In	VDJ	1	47	0.002070210985332335	0.0025845477041517733	45	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-03	01	3	0	7	0	0	4	28	-1	47	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGRASGNTIYF+TCRBV06-04+TCRBJ01-03	TCRBV06-04		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCAGTAGGGCTGTGGGCTGAAGCTTTCTTTGGACAA	CASSEAVGLWAEAFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	5	5	3	6	8	7	26	38	50	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAVGLWAEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGANTGELFF	In	VDJ	1	34	0.0014975994361978594	0.0018696728072587297	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	3	0	0	0	26	-1	-1	37	42														CASSGANTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCGACCGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSPDRIYNEQFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-01	01	5	1	8	3	7	1	19	31	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDRIYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATTTGAGATACGCAGTATTTTGGCCCA		Out	VJ	1	28	0.0012333171827511782		35	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-03	01	1	0	0	5	0	3	29	-1	45	-1	48			01,02											X+TCRBV16-01+TCRBJ02-03	TCRBV16-01		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCGCCGGACACTTGGAGACGTTCTTCGGGCCA	CASSAGHLETFF	In	VDJ	3	127	0.005593974364621415	0.006983777838878196	36	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	15	3	9	29	41	49	44	58			01,02											CASSAGHLETFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATCTTTTACGGAGTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDLLRSSTDTQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	0	8	1	23	40	52	48	53	TCRBV01,TCRBV23													CASSQDLLRSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCACTAGCGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	5.285645068933621E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	5	0	2	3	26	43	53	45	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTCCCAGGGGTCAGCGGAATACGAGCAGTACTTCGGGCCG	CSANSQGSAEYEQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	5	9	26	36	47	41	56		TCRBV20-01,TCRBV20-or09_02												CSANSQGSAEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTYGGSCMTRTATYKCTGTGCCAGCAGCTGGGCTTCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSWASGGTDTQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	1	6	0	22	35	-1	41	47	TCRBV07,TCRBV12													CASSWASGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGGGGGATATGGCTACACCTTCGGTTCG	CASSLGGYGYTF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	36	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	1	5	0	1	23	-1	43	37	44	TCRBV24,TCRBV27													CASSLGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCCGGACAGGGGGGGACATTCAGTACTTCGGCGCC	CASSSRTGGDIQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	1	1	8	3	2	19	32	45	35	47	TCRBV07,TCRBV11													CASSSRTGGDIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTCGGCGGGGGCCCCTCCTACGAGCAGTACTTCGGGCCG	CASSFGGGPSYEQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	0	2	3	18	32	41	34	44	TCRBV07,TCRBV11													CASSFGGGPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCGCGGGGAGAGGGCCTACGAGCAGTACTTCGGGCCG	CASSPRGERAYEQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	2	4	6	18	30	40	34	46	TCRBV07,TCRBV11													CASSPRGERAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCTTGGAGGGGGGAAATTCACCCCTCCACTTTGGGAAC	CASSLEGGNSPLHF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	3	5	1	7	2	2	19	33	41	35	43	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGGNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCACCCCTAAGGATGGGGGGGCTCCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	5.285645068933621E-4		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	5	11	4	24	37	55	48	59	TCRBV11,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGCTCTTGGGGGGAGCAGTACTTCGGGCCG	CASSGSWGEQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	6	1	7	8	0	26	37	-1	45	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSWGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAGGACACGCTGGTATGCAGTACTTCGGGCCG	CASSVGHAGMQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	9	3	9	26	38	46	41	55		TCRBV03-01,TCRBV03-02												CASSVGHAGMQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATTAGGGGGGGATGGAACCACTGAAGCTTTCTTTGGACAA	CASSQLGGDGTTEAFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	4	3	7	23	38	48	41	55	TCRBV01,TCRBV04													CASSQLGGDGTTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTTGGATCTAGTTTTGGGCCTGGACCCAGTAAGACCCAGTACTTCGGGCCA	CASSFGSSFGPGPSKTQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	57	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	1	7	6	22	6	22	33	59	55	65		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGSSFGPGPSKTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACCACAGTTTCAGGGAAACTGTTTTTTGGCAGT	CASRTTVSGKLFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	11	11	0	24	35	-1	46	51		TCRBV24-01,TCRBV24-or09_02												CASRTTVSGKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CASGLAGADTQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	1	2	4	2	0	24	31	-1	33	46		TCRBV24-01,TCRBV24-or09_02												CASGLAGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGACAGTAGACTATGGCTACACCTTCGGTTCG	CASSQDRTVDYGYTF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	3	2	3	18	35	43	37	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRTVDYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCACTAGCGCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLALSSYNEQFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	6	0	2	5	19	31	40	33	45		TCRBV05-06,TCRBV05-07				01,02								CASSPLALSSYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGTACCCWMYCAGACAKCTSTKTACTTCTGTGCCATCATGCCCGGGGGGGGCTCTAACTATGGCTACACCTTCGGTTCG	CAIMPGGGSNYGYTF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	8	0	0	7	3	28	35	50	42	53	TCRBV06,TCRBV24													CAIMPGGGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCWSSSASWCAKCTGTGTACTTCTGTGCCAGCAAGCCGACAGGTACAACACCGTGGGAACATTCAGTACTTCGGCGCC		Out	VDJ	1	14	6.166585913755891E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	2	4	7	4	14	24	34	44	38	58	TCRBV06,TCRBV10,TCRBV12													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGTGCACAATGAGCAGTTCTTCGGGCCA	CASSHVHNEQFF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	10	0	5	3	0	26	40	-1	43	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHVHNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACTAGCAGCAGATATGCAGTATTTTGGCCCA	CSARELAADMQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	7	11	0	9	26	-1	46	40	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARELAADMQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTAGGCCAGGGTAATCAGCCCCAGCATTTTGGTGAT	CSASLGQGNQPQHF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	4	7	1	26	37	49	44	50		TCRBV20-01,TCRBV20-or09_02												CSASLGQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCCTAGCGGGGCGAACTACGAGCAGTACTTCGGGCCG	CSAHPSGANYEQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	3	4	4	26	35	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSAHPSGANYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCGGTAGCGGGACCTACGAGCAGTACTTCGGGCCG	CSALGSGTYEQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	3	2	5	0	26	35	-1	40	48		TCRBV20-01,TCRBV20-or09_02												CSALGSGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCGGACTAGCGGGGGCAGATATGCAGTATTTTGGCCCA	CAIGLAGADMQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	1	2	11	2	7	24	31	46	33	53		TCRBV24-01,TCRBV24-or09_02												CAIGLAGADMQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGTGGACATGAGCATGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	6.166585913755891E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	6	4	1	22	18	29	35	30	57	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAACGACAAAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	6.166585913755891E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	6	0	2	3	18	33	39	35	42	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCTTGGGTGCGGGACCGGGTAAAGAGACCCAGTACTTCGGGCCA	CASSLGAGPGKETQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	3	3	4	7	19	33	43	37	50	TCRBV07,TCRBV23													CASSLGAGPGKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGTGTTAGCGGGGACAGATACGCAGTATTTTGGCCCA	CASSEVLAGTDTQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	3	3	8	0	23	34	-1	42	50	TCRBV02,TCRBV09													CASSEVLAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTATCGGGATACGCAGTATTTTGGCCCA	CASSYRDTQYF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	5	6	2	0	26	39	-1	41	44		TCRBV12-03,TCRBV12-04				01,02								CASSYRDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCTCCTAAATATAATGAGCAGTTCTTCGGGCCA	CASSQSPKYNEQFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	9	7	4	5	26	41	48	45	53		TCRBV03-01,TCRBV03-02				01,02								CASSQSPKYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATCCGGTGGGGGGACTTGGGCACTGAAGCTTTCTTTGGACAA	CSAIRWGDLGTEAFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	4	11	4	26	34	51	45	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIRWGDLGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGACCGACAGGGAGGGGGAGACCCAGTACTTCGGGCCA	CSAGTDREGETQYF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	2	3	5	7	5	26	34	48	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGTDREGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCAGGAACAGGGGCCTTCGGTCAGCCCCAGCATTTTGGTGAT	CATSPGTGAFGQPQHF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	2	6	7	7	24	35	49	42	56		TCRBV24-01,TCRBV24-or09_02												CATSPGTGAFGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGACAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	6.607056336167027E-4		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	5	0	0	0	24	-1	-1	35	40		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCTAACTGGCACTGAAGCTTTCTTTGGACAA	CATSLTGTEAFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	4	3	2	24	36	42	39	44		TCRBV24-01,TCRBV24-or09_02				01,02								CATSLTGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAISDSSGANVLTF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	0	0	23	-1	-1	35	40	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDSSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGAAGGACAGGGTGATAGTGGCTACACCTTCGGTTCG	CASSQEEGQGDSGYTF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	7	4	6	18	35	47	39	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEEGQGDSGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGATCGCCACAATGAGCAGTTCTTCGGGCCA	CASSLDRHNEQFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	1	10	0	5	3	1	18	34	39	37	40	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRHNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTGGACAGGGGGACAGCCCCAGCATTTTGGTGAT	CASSWTGGQPQHF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	1	7	2	1	20	31	43	33	44	TCRBV07,TCRBV23													CASSWTGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCGGGATCGACAGGCCAGCGTCCTGACTTTCGGGGCC	YASSRDRQASVLTF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	4	12	7	4	22	34	47	41	51	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSRDRQASVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCCCCAGGGACAGGGGACAGCTTTCTTTGGACAA		Out	VDJ	1	17	7.487997180989297E-4		35	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	2	10	8	2	26	31	49	39	51	TCRBV12,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCAGCGGTGGCAGATACGCAGTATTTTGGCCCA	CASSQPAVADTQYF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	6	5	4	2	3	26	41	48	43	51		TCRBV03-01,TCRBV03-02				01,02								CASSQPAVADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGATAAGGAGCGAGGGAACCAACTATGGCTACACCTTCGGTTCG	CSAQIRSEGTNYGYTF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	0	2	13	4	26	34	52	47	56		TCRBV20-01,TCRBV20-or09_02												CSAQIRSEGTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGGGAGGGGGCAGCGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	7.487997180989297E-4		47	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	5	0	3	5	4	26	39	51	44	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGAGGCCCTCATTACAATGAGCAGTTCTTCGGGCCA	CASSLGGPHYNEQFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	4	2	7	24	36	44	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLGGPHYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGATTTTAGGGCTATGGGGGAACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPDFRAMGEPNTGELFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	57	TCRBV20						TCRBJ02	TCRBJ02-02	01	5	6	1	0	17	3	24	33	55	50	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDFRAMGEPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGTTGACAGGGGGCGACGAGACCCAGTACTTCGGGCCA	CASSPLTGGDETQYF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	5	5	3	19	31	46	36	49		TCRBV05-06,TCRBV05-07												CASSPLTGGDETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGTCCCCGGTAACACAGATACGCAGTATTTTGGCCCA	CASSLVPGNTDTQYF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	5	2	6	3	19	33	42	39	45	TCRBV05,TCRBV07					01,02								CASSLVPGNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGACGTGGAAACACCATATATTTTGGAGAG	CASSQERRGNTIYF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	2	7	3	2	1	26	43	48	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQERRGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTACCCATGACTAGCGGGAAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	7.928467603400431E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	3	4	7	2	26	38	56	45	58	TCRBV03,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATGCCTAGCGTGTACACCGGGGAGCTGTTTTTTGGAGAA	CSASMPSVYTGELFF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	6	3	5	3	26	37	48	42	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSASMPSVYTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAACAGACAGCTATGGCTACACCTTCGGTTCG	CASSQETDSYGYTF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	4	4	0	18	35	-1	39	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQETDSYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTGGGGTAATTGTGACGGGGACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	7.928467603400431E-4		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	0	16	1	20	31	52	47	53	TCRBV05,TCRBV07,TCRBV23													X+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAAAACTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLKLGANVLTF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	3	10	4	2	1	19	34	39	36	40	TCRBV07,TCRBV11					01,02								CASSLKLGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCGTCCGGGACTAGCGAATGCAGATACGCAGTATTTTGGCCCA	CASSARPGLANADTQYF	In	VDJ	1	18	7.928467603400431E-4	9.898267803134452E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	6	4	7	4	23	36	53	43	57	TCRBV09,TCRBV21					01,02								CASSARPGLANADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCATACCCTCCCATTTCAGGCTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	8.368938025811567E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	16	3	26	38	58	54	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATCTCTAAGACGGCCCGAGGGGCAGATACGCAGTATTTTGGCCCA	CASISKTARGADTQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	7	5	2	4	16	0	26	36	-1	52	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASISKTARGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACGCCGGGGGGGCCAACGCTGAAGCTTTCTTTGGACAA	CSADAGGANAEAFF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	6	6	6	26	34	48	40	54		TCRBV20-01,TCRBV20-or09_02												CSADAGGANAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCAACCCAGGAGGGGCTCATGGCTACACCTTCGGTTCG	CSARDANPGGAHGYTF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	6	10	4	26	40	56	50	60		TCRBV20-01,TCRBV20-or09_02												CSARDANPGGAHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTAGGGCGTGCGGGGACTGCTATATGAAAAACTGTTTTTTGGCAGT	CSARD*GVRGLLYEKLFF	Stop	VDJ	1	19	8.368938025811567E-4		54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	0	10	6	12	5	26	40	58	52	63		TCRBV20-01,TCRBV20-or09_02				01,02								CSARD*GVRGLLYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCGTAGCGGGTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSRSGSSTDTQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	0	2	3	22	34	43	36	46	TCRBV02,TCRBV12					01,02								CASSRSGSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGATCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGITSGANVLTF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	48	TCRBV24						TCRBJ02	TCRBJ02-06	01	6	0	8	0	3	4	24	36	43	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGITSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGACCTCGTGGGACAGGGACAAGGAGGCGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	8.368938025811567E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	0	3	8	11	10	24	31	51	42	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCGGGGTGGCTCAACACCGGGGAGCTATTTTTTGGAGAA	CASSPGWLNTGELFF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	3	17	1	21	23	35	41	36	62	TCRBV09,TCRBV21					01,02								CASSPGWLNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGACGACTCCTCCGAGAAGTACTTCGGGCCG	CASSDDSSEKYF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	11	3	9	26	38	45	41	54		TCRBV12-03,TCRBV12-04				01,02								CASSDDSSEKYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAACAGCCACGGGGCGAATACCGGGGAGCTGTTTTTTGGAGAA	CANSHGANTGELFF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	3	7	0	5	1	4	26	40	46	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSHGANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGATACGCAGTATTTTGGCCCA	CASSQADTQYF	In	VJ	1	20	8.809408448222702E-4	0.0010998075336816058	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	0	0	4	0	0	26	-1	-1	-1	42		TCRBV03-01,TCRBV03-02												CASSQADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCGCCGCGAGGGAGCAGTACTTCGGGCCG	CSARAAAREQYF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	1	7	9	0	26	37	-1	46	50		TCRBV20-01,TCRBV20-or09_02												CSARAAAREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATGGGGGGGACGGGGTATCCCGCACAGATACGCAGTATTTTGGCCCA	CSADGGDGVSRTDTQYF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	1	3	12	26	35	45	38	57		TCRBV20-01,TCRBV20-or09_02												CSADGGDGVSRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAAGAGGGGTTGGAGACAGCCCCAGCATTTTGGTGAT	CASSLKRGWRQPQHF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	45	unresolved						TCRBJ01	TCRBJ01-05	01	6	5	2	7	6	7	24	36	47	42	54	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKRGWRQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTCCGGGCGAAGGCTACACCTTCGGTTCG	CASSLGPGEGYTF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	8	0	8	8	3	24	36	48	44	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPGEGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGGAAACCTTTAGCGGGAGGGATTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	8.809408448222702E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	9	8	4	23	34	53	42	57	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGDSYNEQFF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	6	1	0	0	1	26	-1	45	40	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGATCTACCGGGACTAGCGGGTCCGGGTGGCAGTTCTTCGGGCCA	CASSLAGSTGTSGSGWQFF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	57				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	4	12	10	8	18	35	57	45	65	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGSTGTSGSGWQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCACCCACTCCTAGCGGGGGGCCAAGTTGATGAGCAGTTCTTCGGGCCA	CASSQGHPLLAGGQVDEQFF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	60	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	8	11	8	15	31	53	42	61		TCRBV03-01,TCRBV03-02												CASSQGHPLLAGGQVDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCCCWMCCAGACAKCTSTWTACTTCTGTGCCAGCAGTACCCGGGACAGGGGGTATCACACTGAAGCTTTCTTTGGACAA	CASSTRDRGYHTEAFF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	3	4	4	26	38	53	42	57	TCRBV06,TCRBV24													CASSTRDRGYHTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTATTGGCCGACAATGAGCAGTTCTTCGGGCCA	CASSQVLADNEQFF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	9	0	5	4	2	26	42	49	46	51		TCRBV03-01,TCRBV03-02												CASSQVLADNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACGGGGGGTCTTCCTACGAGCAGTACTTCGGGCCG	CSARDYGGSSYEQYF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	1	1	3	3	26	40	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDYGGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCGGACAGGAGGATGCCTACGAGCAGTACTTTGGGCCG	CASSGQEDAYEQYF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	19	1	23	24	35	43	36	66	TCRBV24,TCRBV27													CASSGQEDAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTCAGGCGGCCGAAAAACTGTTTTTTGGCAGT	CASSLGQAAEKLFF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	42	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	4	4	8	6	5	24	36	46	42	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQAAEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCGAGAGGGACTAGCGGGAGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSREGLAGGGSTDTQYF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	0	0	6	3	20	31	53	37	56	TCRBV04,TCRBV23													CASSREGLAGGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCAATTACCCTTGGGACAGGGGGTCTTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	24	0.0010571290137867241		55				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	1	8	11	4	24	36	58	47	62	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAACCCGAGGGACTAGCGGTCTCTCCTACGAGCAGTACTTCGGGCCG	CSATTRGTSGLSYEQYF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	5	0	8	3	26	36	55	44	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTRGTSGLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTACGTCGGGAGCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSYVGSPYNEQFF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	2	4	2	23	36	46	40	48	TCRBV24,TCRBV27													CASSYVGSPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCCGTTCTAGCGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSRSSGSTDTQYF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	5	0	4	1	22	34	45	38	46	TCRBV05,TCRBV07					01,02								CASSRSSGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCACATCAGGACTAGGGGGGACTGAAGCTTTCTTTGGACAA	CASSLTSGLGGTEAFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	1	8	5	8	5	26	39	54	47	59		TCRBV03-01,TCRBV03-02				01,02								CASSLTSGLGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGTGTGGGGTGAGCAGTTCTTCGGGCCA	CSARDVWGEQFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	6	2	9	5	0	26	40	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDVWGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAGACTCCCGCAGGGTTACGAGCAGTACTTCGGGCCG	CASSLRLPQGYEQYF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	4	9	1	23	38	52	47	53	TCRBV24,TCRBV27													CASSLRLPQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGTAGACATCAGCAATCAGCCCCAGCATTTTGGTGAT	CASVDISNQPQHF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	6	1	3	2	23	32	39	35	41	TCRBV06,TCRBV10													CASVDISNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCGATGGGACAGGGGGCTAGGTAGCGAGCAGTACTTCGGGCCG	CASSSRWDRGLGSEQYF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	0	6	6	7	18	31	49	37	56	TCRBV05,TCRBV11													CASSSRWDRGLGSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCTCCGACAGGGGTGACACTGAAGCTTTCTTTGGACAA	CASSSSDRGDTEAFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	3	5	2	18	31	44	36	46	TCRBV07,TCRBV11													CASSSSDRGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCCTGGGACTAGCGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGDTGELFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	3	0	0	19	-1	-1	35	47	TCRBV05,TCRBV23													CASSLGLAGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGTGACAGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVTGNTGELFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	4	2	0	1	23	-1	43	37	44	TCRBV02,TCRBV09													CASSVTGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGTGGGACCTGGCGGTCAGCCCCAGCATTTTGGTGAT	CASSVGPGGQPQHF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	42							TCRBJ01	TCRBJ01-05	01	4	0	7	6	1	7	24	37	43	38	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPGGQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTAGCATCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	0.0011452230982689513		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	7	5	1	16	26	40	45	41	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGGTCTAGTCAGCCCCAGCATTTTGGTGAT	CASSLSGSSQPQHF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	6	4	5	24	36	45	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGSSQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGACTGATCACAGATACGCAGTATTTTGGCCCA	CASSLVGLITDTQYF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	13	1	10	2	13	3	20	23	41	36	44	TCRBV05,TCRBV11					01,02								CASSLVGLITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGGGGACCTAAACTATGGCTACACCTTCGGTTCG	CASSLGDLNYGYTF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	42	unresolved						TCRBJ01	TCRBJ01-02	01	2	0	7	2	2	3	19	33	40	35	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDLNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCTTAGTAGGACTGATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	0.0011452230982689513		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	13	1	10	2	13	3	19	22	40	35	43	TCRBV05,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTTCTGTGCCAGCAGTTTAGGCGCCAAGAGAACACTGATTGGGGTCGGAAAAGAGAACACTGAAGCTTTCTTTGGACAA	CASSLGAKRTLIGVGKENTEAFF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	69							TCRBJ01	TCRBJ01-01	01	1	6	2	1	20	10	4	20	44	40	54	TCRBV12,TCRBV21	TCRBV12-03,TCRBV12-04,TCRBV21-or09_02,TCRBV21-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAKRTLIGVGKENTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCGGACAGGGGGGGTTACGAGCAGTACTTCGGGCCG	CSPDRGGYEQYF	In	VDJ	1	27	0.0011892701405100648	0.0014847401704701677	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	1	1	4	3	3	26	31	44	34	47		TCRBV20-01,TCRBV20-or09_02												CSPDRGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGTGCACGCCCCTTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	0.0012333171827511782		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTATCGGGACTGACTCCTACGAGTAGTACTTCGGGCCG	CSIGTDSYE*YF	Stop	VDJ	1	28	0.0012333171827511782		36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	10	11	3	13	26	32	41	35	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSIGTDSYE*YF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTGGGACAGGATGCTTGGGGATACGCAGTATTTTGGCCCA	CSASWDRMLGDTQYF	In	VDJ	1	28	0.0012333171827511782	0.001539730547154248	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	4	6	2	9	26	37	47	39	56		TCRBV20-01,TCRBV20-or09_02												CSASWDRMLGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCAAGAACGGGTATCTTCTGGAAACACCATATATTTTGGAGAG	CASSQERVSSGNTIYF	In	VDJ	1	28	0.0012333171827511782	0.001539730547154248	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	8	4	1	1	5	23	40	45	41	50	TCRBV04,TCRBV05					01,02								CASSQERVSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAACAGGGAACCCTGGAAACACCATATATTTTGGAGAG	CASSLTGNPGNTIYF	In	VDJ	1	28	0.0012333171827511782	0.001539730547154248	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	2	2	4	23	36	44	38	48	TCRBV06,TCRBV24													CASSLTGNPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACAATACTAGCGGGGGGTACCTAAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	0.0012333171827511782		52	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	1	5	4	9	23	33	49	37	58	TCRBV02,TCRBV09													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGACAGGGGTCCTTTGAAGCTTTCTTTGGACAA	CSAGQGSFEAFF	In	VDJ	1	29	0.0012773642249922917	0.0015947209238383283	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	7	0	5	26	-1	44	34	49		TCRBV20-01,TCRBV20-or09_02												CSAGQGSFEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGGGAGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSGRASTDTQYF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	0	0	2	26	-1	45	38	47	TCRBV12,TCRBV21													CASSGRASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTAGTTGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSVVGGYTEAFF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	1	3	2	1	22	38	46	40	47		TCRBV12-03,TCRBV12-04												CASSVVGGYTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCACGGAGGGCAGATGGGCGACTGAAGCTTTCTTTGGACAA	YASSTEGRWATEAFF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	2	10	22	34	42	36	52	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSTEGRWATEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGTTGGGGACAGGGTGCAGAAACTGTTTTTTGGCAGT	CASSRVGDRVQKLFF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	11	6	5	26	39	54	45	59		TCRBV03-01,TCRBV03-02												CASSRVGDRVQKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGTTGGGGACGAGCAGTACTTCGGGCCG	CASSRVGDEQYF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	6	2	5	5	0	26	39	-1	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRVGDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCGGACGGCCGGACCCCTAACCTACGAGCAGTACTTCGGGCCG	CASSFRTAGPLTYEQYF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	51	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	1	7	2	4	14	26	38	46	42	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRTAGPLTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCCTCAGTCAAAGTTACAGATACGCAGTATTTTGGCCCA	CATSDASVKVTDTQYF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	5	3	5	8	24	38	46	43	54		TCRBV24-01,TCRBV24-or09_02												CATSDASVKVTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCATTGTATCAGCAGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	0.0014095053517156322		49	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	4	11	6	26	38	53	49	59		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAGGGGAGCTCTGAAGCTTTCTTTGGACAA	CASSLQGSSEAFF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	6	0	4	26	-1	47	41	51		TCRBV12-03,TCRBV12-04												CASSLQGSSEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGGTGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARWVTGANVLTF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	42	TCRBV20						TCRBJ02	TCRBJ02-06	01	2	0	9	2	1	3	26	38	42	39	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARWVTGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTAGCGGGGACAGATACGCAGTATTTTGGCCCA	CSARLAGTDTQYF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	3	1	0	26	37	-1	38	47		TCRBV20-01,TCRBV20-or09_02												CSARLAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGCGGCCAGGGACTTCGGACGTGCCCAGTACTTCGGGCCA	CASSVAARDFGRAQYF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	10	9	11	9	22	33	50	44	59		TCRBV12-03,TCRBV12-04				01,02								CASSVAARDFGRAQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGATAAGAGCGACAGGTGAAAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	0.0014095053517156322		56	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	4	2	10	6	25	41	57	51	63		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCATCCGAGGGAGTGTATGAGAGACCCAGTATTTCGGGCCA		Out	VDJ	1	32	0.0014095053517156322		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02			4	9	2	19	7	19	19	31	43	38	62	TCRBV01,TCRBV05							TCRBJ02-01,TCRBJ02-05						X+X+TCRBJ02-X	unresolved	TCRBD02-01*02	TCRBJ02	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGCGGGAGGGCCGGGAGATACGCAGTATTTTGGCCCA	CSALAGGPGDTQYF	In	VDJ	1	33	0.0014535523939567458	0.0018146824305746495	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	5	1	5	26	35	47	36	52		TCRBV20-01,TCRBV20-or09_02												CSALAGGPGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCCCGACAGGGCAACACTGAAGCTTTCTTTGGACAA	CASSSRQGNTEAFF	In	VDJ	1	34	0.0014975994361978594	0.0018696728072587297	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	2	5	1	20	31	43	36	44	TCRBV11,TCRBV23													CASSSRQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGCAGTATCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	0.0015416464784389727		52	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	4	5	5	3	17	26	38	44	41	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGGGGTTGGAAACACCATATATTTTGGAGAG	CSARVGVGNTIYF	In	VDJ	1	35	0.0015416464784389727	0.00192466318394281	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	5	2	3	1	1	26	39	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSARVGVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGGCGAGGCTAATTGGGGAGAGACCCAGTACTTCGGGCCA	CSARRGEANWGETQYF	In	VDJ	1	35	0.0015416464784389727	0.00192466318394281	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	5	2	4	1	15	26	37	43	38	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGEANWGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAAGACTCRGCCSTGTATSTCTGYGCCAGCAGCCAAGATCCTGCTTCGGCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	35	0.0015416464784389727		52	unresolved						TCRBJ02	TCRBJ02-04	01	0	9	0	0	9	1	23	40	52	49	53	TCRBV04,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTACTTGGACAGGGTGTGGACTGGAAACACCATATATTTTGGAGAG	CASSYLDRVWTGNTIYF	In	VDJ	1	35	0.0015416464784389727	0.00192466318394281	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	3	2	4	6	18	31	43	35	49	TCRBV07,TCRBV11													CASSYLDRVWTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGAGGGGGTTGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGGGWSNQPQHF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	1	0	6	26	-1	47	40	53		TCRBV03-01,TCRBV03-02												CASSQGGGWSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGGGACAGGCGATGTCTCTGGAAACACCATATATTTTGGAGAG	CSASGGTGDVSGNTIYF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	4	0	4	6	26	37	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSASGGTGDVSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAAAAAAACGACAGGGGGCTTGTACGAGCAGTACTTCGGGCCG	CATSDKKTTGGLYEQYF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	0	4	8	3	24	39	57	47	60		TCRBV24-01,TCRBV24-or09_02												CATSDKKTTGGLYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCCTTACGGAGACTAGCGGGAGTTTAACCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	36	0.0015856935206800863		59	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	2	2	2	8	7	19	28	48	36	55		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-06	TCRBV05	TCRBD02-01*02	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCTCAGACAAGAACCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRQEPYNEQFF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	2	4	5	22	34	42	38	47	TCRBV07,TCRBV11													CASSLRQEPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGAGACTAGCGCTATCGAGACCCAGTACTTCGGGCCA	CASSEETSAIETQYF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	6	5	6	5	24	35	49	41	54	TCRBV09,TCRBV21					01,02								CASSEETSAIETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAAAGGGAGCGCCGGGTGCACTATGGCTACACCTTCGGTTCG	CASKRERRVHYGYTF	In	VDJ	1	37	0.0016297405629211999	0.0020346439373109706	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	9	2	3	3	10	26	36	44	39	54		TCRBV03-01,TCRBV03-02												CASKRERRVHYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCTCGAGTCATACAATGAGCAGTTCTTCGGGCCA	CSARGLESYNEQFF	In	VDJ	1	37	0.0016297405629211999	0.0020346439373109706	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	2	4	5	3	26	39	47	44	50		TCRBV20-01,TCRBV20-or09_02												CSARGLESYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGACTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CATGLAGADTQYF	In	VDJ	1	37	0.0016297405629211999	0.0020346439373109706	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	1	2	4	0	0	24	-1	-1	33	46		TCRBV24-01,TCRBV24-or09_02												CATGLAGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGGCAGGGGTTCAGCAGATATGCAGTATTTTGGCCCA	CASSQDPGRGSADMQYF	In	VDJ	1	38	0.0016737876051623134	0.002089634313995051	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	11	6	12	26	43	55	49	67		TCRBV03-01,TCRBV03-02												CASSQDPGRGSADMQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTTTGGGGACCAAAATGAAAAACTGTTTTTTGGCAGT	CASSFGDQNEKLFF	In	VDJ	1	38	0.0016737876051623134	0.002089634313995051	42	unresolved						TCRBJ01	TCRBJ01-04	01	3	0	7	5	2	3	22	36	43	38	46	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGDQNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTCSCTCYCAGACWTCTGTKTAYTTCTGYGCCAGCAGAACGGACAGGGGGTTACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	38	0.0016737876051623134		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	1	2	3	2	23	34	47	37	49	TCRBV06,TCRBV10													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCTCCCGGTGGGGGGCCCGTGCCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	39	0.0017178346474034268		44	TCRBV03						TCRBJ02	TCRBJ02-02	01	11	6	0	6	8	7	26	32	46	40	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCCTGAGGGACCTTTTTGAGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	39	0.0017178346474034268		49	TCRBV24						TCRBJ01	TCRBJ01-04	01	7	0	7	8	7	11	24	35	47	42	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGGGGGAGGGTCCGGACAGGGGAATGAAAAACTGTTTTTTGGCAGT	CRGGGSGQGNEKLFF	In	VDJ	1	41	0.001805928731885654	0.002254605444047292	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	1	2	5	13	0	26	31	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CRGGGSGQGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACACCTAGGGTTACAGATACGCAGTATTTTGGCCCA	CSATPRVTDTQYF	In	VDJ	1	41	0.001805928731885654	0.002254605444047292	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	5	3	3	7	2	26	34	45	41	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPRVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTACTACCCCTCTGTATAGCGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	0.0018499757741267675		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	3	3	14	0	24	36	-1	50	58	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGCGGGAGGAGTCTACAATGAGCAGTTCTTCGGGCCA	CATSDLAGGVYNEQFF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	1	3	0	3	24	-1	50	41	53		TCRBV24-01,TCRBV24-or09_02												CATSDLAGGVYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCCAGGTCCGACCGTCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	0.0018940228163678808		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	4	0	4	9	26	39	47	43	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAGCGGGAGGGCCCTCACCGGGGAACTGTTTTTTGGAGAA	CASSRSGRALTGELFF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	6	0	14	2	14	26	39	51	41	65		TCRBV03-01,TCRBV03-02												CASSRSGRALTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCCGGACAGGGACCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	0.0018940228163678808		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	3	5	3	5	24	35	46	38	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAATCACGGGTAACGATGAAAAACTGTTTTTTGGCAGT	CASSVITGNDEKLFF	In	VDJ	1	43	0.0018940228163678808	0.002364586197415452	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	6	7	5	24	36	47	43	52	TCRBV12,TCRBV21					01,02								CASSVITGNDEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACAGGGGGCGATGGGAACAGATACGCAGTATTTTGGCCCA	CSARQGAMGTDTQYF	In	VDJ	1	46	0.0020261639430912215	0.002529557327467693	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	3	2	7	26	34	46	36	53		TCRBV20-01,TCRBV20-or09_02												CSARQGAMGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAGATGTTTCGATCAATAGCGGGAGAGGTCAAAAACATTCAGTACTTCGGCGCC	CASSQEMFRSIAGEVKNIQYF	In	VDJ	1	46	0.0020261639430912215	0.002529557327467693	63	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	5	2	3	14	4	15	32	55	46	59	TCRBV04,TCRBV23													CASSQEMFRSIAGEVKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCCCCAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSATSPANTGELFF	In	VDJ	1	47	0.002070210985332335	0.0025845477041517733	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	5	0	6	0	26	36	-1	42	45		TCRBV20-01,TCRBV20-or09_02												CSATSPANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACAGGGGGCGTCGGCAATCAGCCCCAGCATTTTGGTGAT	CSARTGGVGNQPQHF	In	VDJ	1	47	0.002070210985332335	0.0025845477041517733	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	0	2	1	4	26	35	47	36	51		TCRBV20-01,TCRBV20-or09_02												CSARTGGVGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGATAGCAAGGGGATACGCAGTATTTTGGCCCA	CATSDG*QGDTQYF	Stop	VDJ	1	47	0.002070210985332335		42	TCRBV24						TCRBJ02	TCRBJ02-03	01	3	5	3	6	8	0	24	39	-1	47	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDG*QGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGACACCCCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQRTPQNTGELFF	In	VDJ	1	48	0.0021142580275734482	0.002639538080835854	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	1	1	5	26	41	47	42	52		TCRBV03-01,TCRBV03-02												CASSQRTPQNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCAGGGTTAAGGATAGGAGAGACCCAGTACTTCGGGCCA	CSAAGLRIGETQYF	In	VDJ	1	48	0.0021142580275734482	0.002639538080835854	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	4	2	11	26	34	41	36	52		TCRBV20-01,TCRBV20-or09_02												CSAAGLRIGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTCCAGTTAGACCCTAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	48	0.0021142580275734482		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	8	6	12	0	23	36	-1	48	52	TCRBV04,TCRBV07,TCRBV17					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCCGACATTACAGGGGGTAGCTTTCTTTGGACAA	CASSPTLQGVAFF	In	VDJ	1	49	0.002158305069814562	0.002694528457519934	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	10	9	1	24	35	52	44	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPTLQGVAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTAGCGCCCTCCCGGGACAGGATGCCCCCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	49	0.002158305069814562		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	8	10	9	23	37	55	47	64	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTACGAACTAGTAGAAGATACGCAGTATTTTGGCCCA	CASSYELVEDTQYF	In	VDJ	1	49	0.002158305069814562	0.002694528457519934	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	8	5	4	4	19	32	41	36	45	TCRBV05,TCRBV23					01,02								CASSYELVEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAGCGACACGCGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	50	0.0022023521120556754		47	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	2	6	1	5	4	24	36	45	41	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAACCTCAGGAGTTCTGGAAACACCATATATTTTGGAGAG	CASNLRSSGNTIYF	In	VDJ	1	52	0.0022904461965379025	0.0028594995875721747	42	unresolved						TCRBJ01	TCRBJ01-03	01	7	4	4	1	4	3	23	33	41	37	44	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNLRSSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGACAGGGGTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	53	0.002334493238779016		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	7	0	1	26	-1	44	38	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACTAGCGGAAATGTAAGGAATGAGCAGTTCTTCGGGCCA	CSARTSGNVRNEQFF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	7	1	10	26	35	46	36	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGNVRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGTACAGGGAAGTCTCGGTCGTGAAAAACTGTTTTTTGGCAGT	CASSLVQGSLGREKLFF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	3	7	1	12	19	35	42	36	54	TCRBV07,TCRBV11													CASSLVQGSLGREKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCGCCGGAGGAGAGACCCAGTACTTCGGGCCA	CASSTAGGETQYF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	1	4	5	0	24	37	-1	42	47	TCRBV09,TCRBV21													CASSTAGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGGGGGACCCCAAGCTTTCTTTGGACAA		Out	VDJ	1	55	0.002422587323261243		37	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	9	0	5	24	-1	45	38	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGCAGGTCTAGCGGTACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	0.0024666343655023563		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	5	9	8	3	26	39	54	47	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGGAAAGGGACGGATTCTTACGAGCAGTACTTCGGGCCG	CASRKGTDSYEQYF	In	VDJ	1	57	0.00251068140774347	0.0031344514709925764	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	4	4	7	19	30	39	34	46	TCRBV05,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKGTDSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTACTCTGTTCAAAAACTGTTTTTTGGCAGT	CASSYSVQKLFF	In	VJ	1	58	0.0025547284499845835	0.0031894418476766566	36	unresolved			unresolved			TCRBJ01	TCRBJ01-04	01	0	0	0	9	0	5	23	-1	40	-1	45	TCRBV06,TCRBV10			TCRBD02										CASSYSVQKLFF+X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCTCTCGGCTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLSASSGNTIYF	In	VDJ	2	59	0.002598775492225697	0.003244432224360737	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	4	8	0	7	0	26	38	-1	45	49	TCRBV12,TCRBV21					01,02								CASSLSASSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCTTGGCGGGGGGAGACTACAATGAGCAGTTCTTCGGGCCA	CSASPLAGGDYNEQFF	In	VDJ	2	59	0.002598775492225697	0.003244432224360737	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	3	7	3	26	37	52	44	55		TCRBV20-01,TCRBV20-or09_02												CSASPLAGGDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCAATTTGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPQFAGSYNEQFF	In	VDJ	2	63	0.002774963661190151	0.003464393731097058	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	1	9	0	26	35	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSAPQFAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGAGACCCAAGCGGGATGGGCCGCAGATACGCAGTATTTTGGCCCA	CASSETQAGWAADTQYF	In	VDJ	2	66	0.0029071047879134916	0.003629364861149299	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	3	4	6	7	24	38	51	44	58		TCRBV24-01,TCRBV24-or09_02												CASSETQAGWAADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTGGGGACCTTCGGGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSLGTFGPSYEQYF	In	VDJ	2	67	0.002951151830154605	0.003684355237833379	48	unresolved						TCRBJ02	TCRBJ02-07	01	2	0	7	0	1	9	19	33	39	34	48	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTFGPSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACCAGGGTCTAACTATGGCTACACCTTCGGTTCG	CASSQGPGSNYGYTF	In	VDJ	2	70	0.0030832929568779454	0.00384932636788562	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	0	3	1	23	39	47	42	48	TCRBV01,TCRBV04													CASSQGPGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGGGACTTAAGGGGACCCAGTACTTCGGGCCA	CASSLGLKGTQYF	In	VDJ	2	72	0.0031713870413601726	0.003959307121253781	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	7	2	6	26	38	46	40	52		TCRBV12-03,TCRBV12-04				01,02								CASSLGLKGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCCCCGGGACAGTAACTCTCGAAATTCACCCCTCCACTTTGGGAAC	CASSPRDSNSRNSPLHF	In	VDJ	2	72	0.0031713870413601726	0.003959307121253781	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	7	5	10	22	33	45	38	55	TCRBV02,TCRBV12													CASSPRDSNSRNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGGTGTGGTGGCGAACGACAAAAACATTCAGTACTTCGGCGCC	CGVVANDKNIQYF	In	VDJ	2	72	0.0031713870413601726	0.003959307121253781	39	TCRBV24						TCRBJ02	TCRBJ02-04	01	14	9	0	3	7	6	24	28	38	35	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CGVVANDKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCTTCGTACAGGGGGCGCACGCAGATACGCAGTATTTTGGCCCA	CSARGFVQGAHADTQYF	In	VDJ	2	74	0.0032594811258423997	0.004069287874621941	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	0	4	7	5	26	39	55	46	60		TCRBV20-01,TCRBV20-or09_02												CSARGFVQGAHADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCAAATCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	75	0.0033035281680835133		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	6	6	3	3	26	36	41	39	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGGTTCTCGGGGACACTGAAGCTTTCTTTGGACAA	CASSLVLGDTEAFF	In	VDJ	2	75	0.0033035281680835133	0.0041242782513060215	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	3	6	0	18	32	-1	38	43	TCRBV11,TCRBV23													CASSLVLGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCCGGATCCGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPDPLAKNIQYF	In	VDJ	2	76	0.003347575210324627	0.004179268627990102	45	unresolved						TCRBJ02	TCRBJ02-04	01	6	1	8	0	3	6	23	34	40	37	46	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDPLAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TTCTGTGCCAGCAGCCAACTTACGAACCCGGACTAGCGGGGGGCACCGTGTCGGGTGACCCAGTACTTCGGGCCA	CASSQLTNPD*RGAPCRVTQYF	Stop	VDJ	2	78	0.0034356692948068535		66	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	1	1	7	11	13	3	18	43	29	56		TCRBV03-01,TCRBV03-02												CASSQLTNPD*RGAPCRVTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGATAATGTCCTATGGCTACACCTTCGGTTCG	CASSEIMSYGYTF	In	VDJ	2	80	0.0035237633792890807	0.004399230134726423	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	2	4	0	8	23	-1	38	35	46	TCRBV06,TCRBV10					unresolved								CASSEIMSYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGATGGTCCTCAGCCCCAGCATTTTGGTGAT	CASSLADGPQPQHF	In	VDJ	2	88	0.003876139717217989	0.0048391531481990656	42							TCRBJ01	TCRBJ01-05	01	0	0	10	6	4	3	18	35	41	39	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADGPQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAGGTGCCGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQVGAGSYNSPLHF	In	VDJ	2	89	0.003920186759459102	0.004894143524883146	51	TCRBV03						TCRBJ01	TCRBJ01-06	01	1	5	4	0	1	6	26	42	46	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGAGSYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGAAGGGGGGGGTATAGGCAATGAGCAGTTCTTCGGGCCA	CASSEGGGIGNEQFF	In	VDJ	2	90	0.003964233801700216	0.004949133901567226	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	9	0	6	0	6	23	-1	46	39	52	TCRBV01,TCRBV04													CASSEGGGIGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAAGGGATAGTCGGTGAGACCCAGTACTTCGGGCCA	CATSDLQGIVGETQYF	In	VDJ	2	90	0.003964233801700216	0.004949133901567226	48	TCRBV24						TCRBJ02	TCRBJ02-05	01	0	0	8	5	3	8	24	42	49	45	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLQGIVGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCACACCCAGTTGAGAGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSHTQLRGGTGELFF	In	VDJ	3	100	0.004404704224111351	0.005499037668408029	51	unresolved						TCRBJ02	TCRBJ02-02	01	5	5	1	5	14	1	18	30	50	44	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTQLRGGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCTTACAGGGTTGGCTTTCTTTGGACAA	CATSDPLTGLAFF	In	VDJ	3	125	0.005505880280139189	0.006873797085510036	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	11	6	3	24	39	51	45	54		TCRBV24-01,TCRBV24-or09_02												CATSDPLTGLAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCCGGGACAGGGCTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	137	0.006034444787032551		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	3	0	7	3	24	36	52	43	55	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCACCCCCTCCCTTTGTGGGTTCTCGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	160	0.007047526758578161		52	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	0	9	7	19	6	26	34	56	53	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GGACTCRGCCRTGTATSKCTGTGCCAGTTCCTCAGGGAGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSSGRVQETQYF	In	VDJ	4	162	0.0071356208430603885	0.008908441022821007	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	9	0	1	7	1	19	27	41	34	42	TCRBV07,TCRBV12													CASSSGRVQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGACAGAGACGCTGAAGCTTTCTTTGGACAA	CASSQADRDAEAFF	In	VDJ	5	192	0.008457032110293793	0.010558152323343416	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	6	1	5	26	42	49	43	54		TCRBV03-01,TCRBV03-02												CASSQADRDAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAACTAGATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	6	218	0.009602255208562746		38	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	8	3	1	2	26	37	43	38	45		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCTACTTCGACAGGGGTTTGAAAAACTGTTTTTTGGCAGT	CATLLRQGFEKLFF	In	VDJ	6	236	0.010395101968902788	0.012977728897442947	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	2	2	7	7	2	24	33	48	40	50		TCRBV24-01,TCRBV24-or09_02												CATLLRQGFEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGTTGGGAAACACCATATATTTTGGAGAG	CASSVLGNTIYF	In	VJ	10	390	0.017178346474034267	0.02144624690679131	36	unresolved						TCRBJ01	TCRBJ01-03	01	5	0	0	4	0	6	24	-1	36	-1	42	TCRBV09,TCRBV21													CASSVLGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCGACCTAGGCGGGTTTGTCCAGTACTTCGGGCCA	CASSTDLGGFVQYF	In	VDJ	11	424	0.01867594591023213	0.023315919714050042	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	4	10	9	5	24	37	51	46	56	TCRBV09,TCRBV21					01,02								CASSTDLGGFVQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGTCCGGGAGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVREPYNEQFF	In	VDJ	12	477	0.021010439149011143	0.026230409678306296	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	2	2	2	1	23	39	47	41	48	TCRBV04,TCRBV23													CASSQVREPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGTCCGGGCGCACAAGAGACCCAGTACTTCGGGCCA	CASSQGPGAQETQYF	In	VDJ	1	34	0.0014975994361978594	0.0018696728072587297	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	3	8	0	2	6	3	23	37	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGPGAQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATAGCGTCCCGGGCACCTATAATTCACCCCTCCACTTTGGGAAC	CASSHSVPGTYNSPLHF	In	VDJ	1	40	0.0017618816896445403	0.0021996150673632116	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	5	6	2	0	9	23	-1	42	37	51						01,02							Vb 7.1	CASSHSVPGTYNSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD02-01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTCCGGGCTGGGACGAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSSGLGRVNEKLFF	In	VDJ	2	73	0.003215434083601286	0.004014297497937861	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	5	0	7	4	8	4	23	35	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSSGLGRVNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGAAGAGACTGACAGGGGGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEETDRGTTNEKLFF	In	VDJ	3	113	0.004977315773245826	0.006213912565301073	54	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	1	0	4	1	23	40	53	44	54													Vb 7.1	CASSEETDRGTTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATCTTTTACGGGGTAGCACAGATACGCAGTATTTTGGCCCA	XASSQDLLRGSTDTQYF	In	VDJ	3	129	0.0056820684491036425	0.0070937585922463565	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	0	7	1	23	40	52	47	53													Vb 7.1	XASSQDLLRGSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTGTAGCGGGGAGAGGTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	5.726115491344756E-4		43	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	3	6	0	6	22	-1	46	38	52														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCGGGGGACTAGCGGAATCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	0.0016737876051623134		47	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	6	4	4	22	34	49	38	53						01,02								X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCCCACCGTAACTCCTACGAGCAGTACTTCGGGCCG	CASSPHRNSYEQYF	In	VDJ	1	41	0.001805928731885654	0.002254605444047292	42	TCRBV12	TCRBV12-01	01				TCRBJ02	TCRBJ02-07	01	5	3	7	0	4	5	22	34	40	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHRNSYEQYF+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAAGACAGATTACGTTCCAAGTCCGCAGATACGCAGTATTTTGGCCCA	CATSKDRLRSKSADTQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	5	4	0	17	18	-1	38	35	55														CATSKDRLRSKSADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCACGCCAGGGGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CATTPGGTGANVLTF	In	VDJ	1	29	0.0012773642249922917	0.0015947209238383283	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	4	1	2	3	2	18	28	38	31	40														CATTPGGTGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGGACAGATCGTACCAAGAGACCCAGTACTTCGGGCCA	CATSGDRSYQETQYF	In	VDJ	2	74	0.0032594811258423997	0.004069287874621941	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	0	1	5	18	30	38	31	43														CATSGDRSYQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCGCGGCCCACCACAGATACGCAGTATTTTGGCCCA	CATSPRPTTDTQYF	In	VDJ	2	77	0.0033916222525657404	0.004234259004674182	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	2	2	5	18	30	36	32	41						01,02								CATSPRPTTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCGTGAGGTAGGCTAGCGGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	80	0.0035237633792890807		50	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	4	12	1	18	30	49	42	50						01,02								X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGCACGTGGAAGACAGGGGGCATTAGGAGCTTTCTTTGGACAA	CATSSARGRQGALGAFF	In	VDJ	6	242	0.01065938422234947	0.01330767115754743	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	0	10	11	6	18	32	53	43	59														CATSSARGRQGALGAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAAGAAAGGGCCGGGGGTCGGGGGACCCAGCATTTTGGTGAT	CASSQERAGGRGTQHF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	48	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	11	11	8	18	30	47	41	55														CASSQERAGGRGTQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTATCCGGGACAGGGCGGTCAGCCCCAGCATTTTGGTGAT	CASSSYPGQGGQPQHF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	6	7	3	18	31	47	38	50														CASSSYPGQGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCCCCCCGGGGGGTACACAGATACGCAGTATTTTGGCCCA	CASSLDPPGGYTDTQYF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	1	2	6	2	18	35	48	41	50														CASSLDPPGGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCACCCACGGACAAGGGTGTGGGTCCGGGAGACCCAGTACTTCGGGCCA	CASSFHPRTRVWVRETQYF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	5	8	15	18	32	45	40	60														CASSFHPRTRVWVRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACAGGGTTTGAAGCTTTCTTTGGACAA	CASSLEGTGFEAFF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	7	1	2	18	35	45	36	47														CASSLEGTGFEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCAGCAATACAGGGATGGAGGAGACCCAGTACTTCGGGCCA	CASSSNTGMEETQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	5	6	6	18	30	42	36	48														CASSSNTGMEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTTGGGGCTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSLGWGFMNTEAFF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	0	3	4	18	34	42	37	46														CASSLGWGFMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGACAGGAATCGCCTACGAGCAGTACTTCGGGCCG	CASSQGTGIAYEQYF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	2	3	5	18	30	41	33	46														CASSQGTGIAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGCTAGCTCGTGGGATACGCAGTATTTTGGCCCA	CASSLVASSWDTQYF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	7	6	3	6	18	34	42	37	48						01,02								CASSLVASSWDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCCCACCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	7.928467603400431E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	3	7	6	5	2	18	34	41	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGTCCCGGGACCTCCTACGAGCAGTACTTCGGGCCG	CASSRGPGTSYEQYF	In	VDJ	1	19	8.368938025811567E-4	0.0010448171569975254	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	7	0	9	0	18	30	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGPGTSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGAAAAATCAGGACACTCTGTCGACACTGAAGCTTGGACAA		Out	VDJ	1	19	8.368938025811567E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	18	10	18	18	29	44	39	62														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGTGGAGACTAGCGGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSMWRLAGGQETQYF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	2	7	1	18	30	50	37	51														CASSMWRLAGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGTCGCTGGGAATGAGCAGTTCTTCGGGCCA	CASSLGVAGNEQFF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	9	7	8	0	18	34	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVAGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGCGTAACTGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGVTGQETQYF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	2	2	9	18	30	36	32	45														CASSLGVTGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCCCTGAAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGPEAYNEQFF	In	VDJ	1	29	0.0012773642249922917	0.0015947209238383283	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	2	0	7	18	-1	36	32	43														CASSLGPEAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGAGCCCGACGACCGGGGAGCTGTTTTTTGGAGAA	CASSLVSPTTGELFF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	2	7	5	7	1	18	34	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSPTTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACCGCCCCTAGCTTAATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPTAPSLISNQPQHF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	7	0	10	5	18	30	45	40	50						01,02								CASSPTAPSLISNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGACGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGRNTGELFF	In	VDJ	2	62	0.0027309166189490378	0.003409403354412978	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	0	7	1	2	1	18	33	40	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGRNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGGACAGGGTGGGGGAGATACGCAGTATTTTGGCCCA	CASSYGQGGGDTQYF	In	VDJ	2	76	0.003347575210324627	0.004179268627990102	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	5	2	6	18	31	41	33	47														CASSYGQGGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGATAACAGGGACCCGGTCCTACGAGCAGTACTTCGGGCCG	CASSSITGTRSYEQYF	In	VDJ	2	86	0.0037880456327357617	0.004729172394830904	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	1	5	6	18	31	42	36	48														CASSSITGTRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATAGTATAGCAAATCAGCCCCAGCATTTTGGTGAT	CASSYSIANQPQHF	In	VDJ	2	91	0.0040082808439413295	0.005004124278251306	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	5	7	4	6	1	18	31	41	37	42						01,02								CASSYSIANQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCCCAGACTTCTCTGGAAACACCATATATTTTGGAGAG	CASSLGPDFSGNTIYF	In	VDJ	2	94	0.00414042197066467	0.005169095408303547	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	8	0	0	0	8	18	-1	36	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPDFSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAACAGGCGGGGGGGCAGGTAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	138	0.006078491829273665		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	5	7	5	18	28	44	35	49														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTTAAACGGACAGGGCGGCTGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	16	7.047526758578161E-4		52	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	12	1	3	4	12	6	26	31	51	43	57														X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCGGGGAAAACCAAGAGACCCAGTACTTCGGGCCA	CASGLAGENQETQYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	3	0	1	3	26	42	48	43	51														CASGLAGENQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCCTACGGGGGGGGGCGGGAACAATGAGCAGTTCTTCGGGCCA	CASTPTGGGGNNEQFF	In	VDJ	1	23	0.0010130819715456108	0.0012647786637338466	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	8	0	5	11	7	26	31	50	42	57														CASTPTGGGGNNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCTATCGACCATCTATGGCTACACCTTCGGTTCG	CASTLSTIYGYTF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	12	2	7	4	12	3	26	31	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLSTIYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGATCGACAGTTCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	0.002422587323261243		35	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	6	3	3	26	37	45	40	48														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGACAGACGAAACACTGAAGCTTTCTTTGGACAA	CASGLVDRRNTEAFF	In	VDJ	3	130	0.005726115491344756	0.0071487489689304375	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	2	1	4	26	43	49	44	53														CASGLVDRRNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAACGGACCACAGGGGAAGAACACTGAAGCTTTCTTTGGACAA	CANGPQGKNTEAFF	In	VDJ	4	164	0.007223714927542616	0.009018421776189167	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	3	2	1	9	2	26	31	47	40	49														CANGPQGKNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCGACACTAGCGACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTLATSSYNEQFF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	6	0	6	5	20	31	44	37	49						01,02								CASSPTLATSSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGACCTGGGGGGGGCTAATGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	13	5.726115491344756E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	0	4	4	7	20	31	42	35	49														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCCGGGGCAGGGTGGGCACTGAAGCTTTCTTTGGACAA	CASSPRGRVGTEAFF	In	VDJ	1	14	6.166585913755891E-4	7.69865273577124E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	6	4	3	4	9	4	20	31	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGRVGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGCGCGAGCGGGAGTAAGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	7.487997180989297E-4		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	8	8	5	20	31	47	39	52														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTAAGTGGCCCAGGAGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	0.0011011760560278377		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	1	3	11	1	20	33	49	44	50														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGGGGCGCCGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	32	0.0014095053517156322		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	0	1	1	3	20	31	40	32	43														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGTACTACTCCGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	0.0016297405629211999		40	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	3	9	0	1	7	20	28	33	29	40						01,02								X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAATGGCCCCTAGAGACCCAGTACTTCGGGCCA	CASSQEWPLETQYF	In	VDJ	1	55	0.002422587323261243	0.0030244707176244156	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	9	0	4	4	4	20	35	42	39	46														CASSQEWPLETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAACGGGCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQRAANTEAFF	In	VDJ	2	61	0.002686869576707924	0.0033544129777288976	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	8	0	1	1	3	20	35	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRAANTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGCCCGGACCAAGAGACCCAGTACTTCGGGCCA	CASSYAGPDQETQYF	In	VDJ	1	12	5.285645068933621E-4	6.598845202089635E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	4	0	0	5	23	-1	43	38	48						01,02								CASSYAGPDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTTTCACAGCGGGAGTATCACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	5.726115491344756E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	0	9	7	23	34	51	43	58														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTAGACAGGGGGAATATGGCTACACCTTCGGTTCG	CASSYPRQGEYGYTF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	1	5	4	2	23	38	51	42	53														CASSYPRQGEYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTGGGTCAATGAGCAGTTCTTCGGGCCA	CASSSWVNEQFF	In	VDJ	1	13	5.726115491344756E-4	7.148748968930437E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	4	0	9	6	3	1	23	36	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGACAGGGGCCCTTCCCAATTTTAGTCGACCCAGTACTTCGGGCCA	CASSPDRGPSQF*STQYF	Stop	VDJ	1	16	7.047526758578161E-4		54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	2	7	4	18	23	34	46	38	64														CASSPDRGPSQF*STQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGCCGCCCTTGTTGAAAACACCATATATTTTGGAGAG	CASSPAALVENTIYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	9	0	6	2	12	23	35	40	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAALVENTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGACGGGACAGGGAAAGAGACCCAGTACTTCGGGCCA	CASSPDGTGKETQYF	In	VDJ	1	16	7.047526758578161E-4	8.798460269452845E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	3	6	1	23	35	50	41	51														CASSPDGTGKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATATCGAGCGGCAGGGGGGAGTATGGCTACACCTTCGGTTCG	CASSISSGRGEYGYTF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	5	12	3	23	34	53	46	56														CASSISSGRGEYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCAGACTCGGACAGGCAACTCCTACGAGCAGTACTTCGGGCCG	CASSPQTRTGNSYEQYF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	0	10	3	23	35	52	45	55														CASSPQTRTGNSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACGTTCGTCTATGGCTACACCTTCGGTTCG	CASSYSTFVYGYTF	In	VDJ	1	20	8.809408448222702E-4	0.0010998075336816058	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	2	7	4	0	6	23	-1	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTFVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGAGACGGCAATCAGCCCCAGCATTTTGGTGAT	CASRRDGNQPQHF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	2	7	2	4	1	23	34	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRDGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAAGGACTAGCGGCCAATGRGCAGTTCTTCGGGCCA	CASSYQGLAANXQFF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	5	6	3	1	23	38	51	41	52						01,02								CASSYQGLAANXQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACGTCCAGGCTCCTCCCGTATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	9.249878870633837E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	4	4	6	11	23	36	46	42	57														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGGGGAGATCGGACTACGAGCAGTACTTCGGGCCG	CASTGGRSDYEQYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	1	3	1	8	23	33	41	34	49														CASTGGRSDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCTCTTAGGTCGGAAGGGACCCTACGAGCAGTACTTCGGGCCG	CASTLLGRKGPYEQYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	0	7	2	16	0	23	33	-1	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLLGRKGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCGCGACTAGCGGGAGGACGGGCGAGCAGTACTTCGGGCCG	CASSYTATSGRTGEQYF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	1	6	5	5	23	38	56	43	61														CASSYTATSGRTGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGAAATGAGCAGTTCTTCGGGCCA	CASSLQGNEQFF	In	VDJ	1	22	9.690349293044972E-4	0.0012097882870497664	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	7	1	1	23	36	43	37	44														CASSLQGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGCCTTCGTCGGACTATGGCTACACCTTCGGTTCG	CASSYLPSSDYGYTF	In	VDJ	1	24	0.0010571290137867241	0.001319769040417927	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	5	3	9	0	23	39	-1	48	51						01,02								CASSYLPSSDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGCAACGGAATGTAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	0.0011011760560278377		49	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	8	10	23	35	46	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCTAGGTCTTGGAGAGCAGTTCTTCGGGCCA	CASSYLGLGEQFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	10	1	8	23	37	42	38	50						01,02								CASSYLGLGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGACAGAGGAAATTCACCCCTCCACTTTGGGAAC	CASRDRGNSPLHF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	5	7	1	4	23	32	40	33	44														CASRDRGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCTCAGGGGCTCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPQGLSNTGELFF	In	VDJ	1	26	0.0011452230982689513	0.0014297497937860873	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	0	4	4	23	34	44	38	48														CASRPQGLSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACTAGTTTGGGCTCTGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	0.0011452230982689513		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	8	6	2	10	23	36	44	38	54						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGATTAGGGCCGTCAGAGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYPD*GRQRSNQPQHF	Stop	VDJ	1	31	0.0013654583094745189		57	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	5	3	1	7	10	23	38	49	45	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPD*GRQRSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSYPPANTEAFF	In	VDJ	1	33	0.0014535523939567458	0.0018146824305746495	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	4	5	1	4	1	23	38	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPPANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTTTGGTCACCGAGCAGTACTTCGGGCCG	CASSYSLVTEQYF	In	VDJ	1	33	0.0014535523939567458	0.0018146824305746495	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	10	6	3	4	23	40	45	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSLVTEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCAGGAGTGTATTGGGAGATGAGCAGTTCTTCGGGCCA	CASSYFRSVLGDEQFF	In	VDJ	1	33	0.0014535523939567458	0.0018146824305746495	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	2	8	13	0	23	39	-1	52	57														CASSYFRSVLGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCGGGACAGGGATCACAGATACGCAGTATTTTGGCCCA	CAAGTGITDTQYF	In	VDJ	1	34	0.0014975994361978594	0.0018696728072587297	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	0	3	2	3	2	23	29	41	32	43														CAAGTGITDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCTAGCGGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASNLAGGSYEQYF	In	VDJ	1	39	0.0017178346474034268	0.002144624690679131	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	4	1	1	2	1	23	33	46	35	47														CASNLAGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTGGGGATTGAGCAGTTCTTCGGGCCA	CASSEVGIEQFF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	0	8	9	6	1	23	35	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVGIEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGGTCGGGGGACAGGGCGCTCTGGAAACACCATATATTTTGGAGAG	CASSYWGRGTGRSGNTIYF	In	VDJ	1	44	0.0019380698586089944	0.0024195765740995328	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	3	0	8	2	23	39	56	47	58														CASSYWGRGTGRSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAATGACCCCGACAGGGGGCGTGAAAAAGACCCAGTACTTCGGGCCA	CASRMTPTGGVKKTQYF	In	VDJ	1	47	0.002070210985332335	0.0025845477041517733	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	6	9	7	23	34	53	43	60														CASRMTPTGGVKKTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACACGGACAGGGATGGCCTATGGCTACACCTTCGGTTCG	CASSTRTGMAYGYTF	In	VDJ	1	48	0.0021142580275734482	0.002639538080835854	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	4	5	23	35	47	39	52														CASSTRTGMAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTCTAGCGGGGGGGCTATATGAGCAGTTCTTCGGGCCA	CASSPLAGGLYEQFF	In	VDJ	1	49	0.002158305069814562	0.002694528457519934	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	8	4	4	23	34	50	38	54														CASSPLAGGLYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGAGGGACAGTACATGAGCAGTTCTTCGGGCCA	CASRGTVHEQFF	In	VDJ	1	53	0.002334493238779016	0.0029144899642562553	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	5	8	3	3	23	32	42	35	45														CASRGTVHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGAGTCCCGGGACAGGGGGCGAAGGAGCTTTCTTTGGACAA	CASSQSPGTGGEGAFF	In	VDJ	1	54	0.0023785402810201296	0.0029694803409403355	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	10	9	5	23	35	56	44	61														CASSQSPGTGGEGAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACCGGAGACAGGTCCTAACTATGGCTACACCTTCGGTTCG	CASSYSPETGPNYGYTF	In	VDJ	1	54	0.0023785402810201296	0.0029694803409403355	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	4	0	6	2	23	40	52	46	54														CASSYSPETGPNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGACTCCACAGATACGCAGTATTTTGGCCCA	CASSYSDSTDTQYF	In	VDJ	1	55	0.002422587323261243	0.0030244707176244156	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	2	1	1	23	40	45	41	46						01,02								CASSYSDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTTTCAATTACGAGCAGTACTTCGGGCCG	CASSYSFNYEQYF	In	VDJ	1	56	0.0024666343655023563	0.003079461094308496	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	4	6	4	5	2	23	38	45	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSFNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGAACAGGGATTGGGCACAGATACGCAGTATTTTGGCCCA	CASSVEQGLGTDTQYF	In	VDJ	2	59	0.002598775492225697	0.003244432224360737	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	1	5	5	23	35	46	40	51														CASSVEQGLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCAAGCGGGAGCTCGAGCAGATACGCAGTATTTTGGCCCA	CASTQAGARADTQYF	In	VDJ	2	72	0.0031713870413601726	0.003959307121253781	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	6	2	4	4	6	23	33	45	37	51														CASTQAGARADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGGGGGCCGGAAAAACTGTTTTTTGGCAGT	CASSRDRGPEKLFF	In	VDJ	2	72	0.0031713870413601726	0.003959307121253781	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	0	8	2	2	23	34	48	36	50														CASSRDRGPEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCAGGGAAGGAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	73	0.003215434083601286		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	5	1	5	23	40	46	41	51														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGAGGATGGATTTTACAATGAGCAGTTCTTCGGGCCA	CASSYEDGFYNEQFF	In	VDJ	2	78	0.0034356692948068535	0.004289249381358262	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	4	1	8	23	37	42	38	50														CASSYEDGFYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCCAGCGGGACTCCCCCTCCTACGAGCAGTACTTCGGGCCG	CAAQRDSPSYEQYF	In	VDJ	2	84	0.003699951548253535	0.004619191641462744	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	6	3	0	4	6	23	29	40	33	46														CAAQRDSPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGGCGTCGGCACCCCTCCACTTTGGGAAC	CASSYSTGASAPLHF	In	VDJ	3	103	0.0045368453508346914	0.005664008798460269	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	2	11	0	6	23	-1	48	40	54														CASSYSTGASAPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGATTTAGGGTAGAGAACACTGAAGCTTTCTTTGGACAA	CASSYSGFRVENTEAFF	In	VDJ	3	116	0.005109456899969167	0.006378883695353313	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	8	1	0	11	23	-1	44	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGFRVENTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCTGGGACTAGCGGGAGGGTCGGGGAGCTGTTTTTTGGAGAA	CASSYSAGTSGRVGELFF	In	VDJ	5	179	0.007884420561159318	0.00984327742645037	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	0	0	7	4	1	23	40	60	44	61														CASSYSAGTSGRVGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGAACTCTGGAAACACCATATATTTTGGAGAG	CASSQNSGNTIYF	In	VDJ	5	188	0.00828084394132934	0.010338190816607093	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	5	0	0	2	23	-1	38	35	40														CASSQNSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACCCAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSDPGSYEQYF	In	VDJ	1	15	6.607056336167027E-4	8.248556502612042E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	1	4	0	24	36	-1	40	45													Vb 18	CASSDPGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAGGACAGGAGGCGAACACTGAAGCTTTCTTTGGACAA	CASSRGQEANTEAFF	In	VDJ	1	17	7.487997180989297E-4	9.348364036293648E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	1	2	4	24	37	46	39	50													Vb 18	CASSRGQEANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGTTTTAGCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVLAGSTDTQYF	In	VDJ	1	21	9.249878870633837E-4	0.001154797910365686	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	3	0	4	0	24	36	-1	40	48													Vb 18	CASSVLAGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCGAGGGGCGGATGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRGADGNQPQHF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	6	5	2	2	3	6	24	35	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRGADGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGTCAGCTCACCACAGTCGCAGGACAGGACCTACACCGGGGAGCTGTTTTTTGGAGAA	CVSSPQSQDRTYTGELFF	In	VDJ	1	25	0.0011011760560278377	0.0013747594171020072	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	4	3	7	4	24	40	54	47	58													Vb 18	CVSSPQSQDRTYTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSPQQGYNEQFF	In	VDJ	1	29	0.0012773642249922917	0.0015947209238383283	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	3	3	0	24	38	-1	41	47													Vb 18	CASSPQQGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTCCCTCCAGCACAGATACGCAGTATTTTGGCCCA	CASSPLPSSTDTQYF	In	VDJ	1	30	0.0013214112672334053	0.0016497113005224085	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	10	0	4	2	24	40	46	44	48						01,02							Vb 18	CASSPLPSSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCCTCGGATTTTTATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	0.0013654583094745189		44	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	1	8	7	5	5	24	41	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGCAGGGTTTAGCAGGAAGCTATGGCTACACCTTCGGTTCG	CASSPGQGLAGSYGYTF	In	VDJ	1	31	0.0013654583094745189	0.001704701677206489	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	4	12	24	38	47	42	59													Vb 18	CASSPGQGLAGSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATAGGGCCGGTCAACAATGAGCAGTTCTTCGGGCCA	CASSPIGPVNNEQFF	In	VDJ	1	32	0.0014095053517156322	0.001759692053890569	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	5	3	5	3	7	24	38	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPIGPVNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGACCTGGAAACACTATATATTTTGGAGAG		Out	VDJ	1	34	0.0014975994361978594		40	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	1	8	13	8	6	24	38	49	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGACTCCCCCGTGGAAGTCAGCCCCAGCATTTTGGTGAT	CASSQGLPRGSQPQHF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	1	10	6	2	12	24	37	44	39	56						01,02							Vb 18	CASSQGLPRGSQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGACAGGGTAAGGGGTCAGCCCCAGCATTTTGGTGAT	CASSPMDRVRGQPQHF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	6	2	7	24	39	49	41	56													Vb 18	CASSPMDRVRGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGTTCCGGGACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSPRSGTGNQPQHF	In	VDJ	1	36	0.0015856935206800863	0.0019796535606268905	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	4	7	0	24	38	-1	45	54													Vb 18	CASSPRSGTGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACCTCGACTACCTACGAGCAGTACTTCGGGCCG	CASSPTSTTYEQYF	In	VDJ	1	42	0.0018499757741267675	0.002309595820731372	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	9	2	5	0	24	39	-1	44	49						01,02							Vb 18	CASSPTSTTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCGCGGACAGGAATAATTCACCCCTCCACTTTGGGAAC	CASSAADRNNSPLHF	In	VDJ	1	45	0.001982116900850108	0.002474566950783613	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	5	5	1	24	36	48	41	49													Vb 18	CASSAADRNNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGATGGGCACTGAAGCTTTCTTTGGACAA	CASSPGMGTEAFF	In	VDJ	1	55	0.002422587323261243	0.0030244707176244156	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	8	4	0	4	24	-1	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGMGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGGCAGCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPEAASNQPQHF	In	VDJ	2	67	0.002951151830154605	0.003684355237833379	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	1	1	0	5	24	-1	43	38	48													Vb 18	CASSPEAASNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGTCCGCGCCCATCTGGCACAGATACGCAGTATTTTGGCCCA	CASSPRPRPSGTDTQYF	In	VDJ	2	70	0.0030832929568779454	0.00384932636788562	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	6	1	6	8	24	38	47	44	55						01,02							Vb 18	CASSPRPRPSGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACAGGTCCTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTGPATNEKLFF	In	VDJ	2	89	0.003920186759459102	0.004894143524883146	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	4	0	1	5	24	38	44	39	49													Vb 18	CASSPTGPATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACAGGGTAATGAGCAGTTCTTCGGGCCA	CASSRQGNEQFF	In	VDJ	2	93	0.004096374928423557	0.0051141050316194665	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	7	0	1	24	-1	44	37	45													Vb 18	CASSRQGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTGCCATGAGACAAGAGACCCAGTACTTCGGGCCA	CASSPAMRQETQYF	In	VDJ	3	112	0.004933268731004713	0.006158922188616992	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	2	2	9	1	24	35	47	44	48													Vb 18	CASSPAMRQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTACCCGATAACACTGAAGCTTTCTTTGGACAA	CASSPLPDNTEAFF	In	VDJ	5	187	0.008236796899088227	0.010283200439923014	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	2	8	2	7	1	24	38	47	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLPDNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7362A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	567	129	11	0	503	407	86	10	0	22703	18185	4138	380	0	0.0681904852	8.07774925	0.0712382495	8.33509254				3645	0.14882718	0.0262304097	0.0347971618	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:36	Age (Range):65+ Years (Old Age),Age:76 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 449,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 351,treatment:nact,type of chemo:carbo/taxol	0.7997178907554428	MSKCC- Snyder- P01-01		542.0	
